Integrated Filing — IndAS



General information about company

Scrip Code 532321
NSE Symbol ZYDUSLIFE
MSEI Symbol NOTLISTED
ISIN INE010B01027
Name of company ZYDUS LIFESCIENCES LIMITED
Type of company Main Board
Class of security Equity
Date of start of financial year 01-04-2026
Date of end of financial year 31-03-2027
Date of board meeting when results were approved 04-11-2026
Date on which prior intimation of the meeting for considering financial results was informed to the exchange 19-10-2026
Description of presentation currency INR
Level of rounding used in financial results Lakhs
Reporting Type Quarterly
Reporting Quarter Second quarter
Nature of report standalone or consolidated Standalone
Whether results are audited or unaudited for the quarter ended Unaudited
Whether results are audited or unaudited for the Year to date for current period ended/year ended Unaudited
Segment Reporting Single segment
Description of single segment Pharmaceuticals
Start date and time of board meeting 04-11-2026   10:50:00
End date and time of board meeting 04-11-2026   12:10:00
Whether cash flow statement is applicable on company Yes
Type of cash flow statement Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification Not applicable
Whether the company has any related party? Yes
Whether the company has entered into any Related Party transaction during the selected half year for which it wants to submit disclosure? Yes
(I) We declare that the acceptance of fixed deposits by the bans/Non-Banking Finance Company are at the terms uniformly applicable/offered to all shareholders/public NA
(II) We declare that the scheduled commercial bank, as per RBI circular RBI/DBR/2015-16/19 dated March 03, 2016, has allowed additional interest of one per cent per annum, over and above the rate of interest mentioned in the schedule of interest rates on savings or a term deposits of banks staff and their exclusive associations as well as on deposits of Chairman, Chairman & Managing Director, Executive Director or such other Executives appointed for a fixed tenure. NA
Whether the company is a high value debt listed entity according to regulation 15 (1A)? No
(a) If answer to above question is Yes, whether complying with proviso to regulation 23 (9), i.e., submitting RPT disclosures on the day of results publication?
(b) If answer to above question is No, please explain the reason for not complying.
Whether the updated Related Party Transactions (RPT) Policy (in compliance with Reg. 23 of SEBI LODR) has been uploaded on the website of the Company? Yes
Latest Date on which RPT policy is updated 24-03-2025
Indicate Company website link for updated RPT policy of the Company www.zyduslife.com
Whether statement on deviation or variation for proceeds of public issue, rights issue, preferential issue, qualified institutions placement etc. is applicable to the company for the current quarter? No
No. of times funds raised during the quarter
Whether the disclosure for the Default on Loans and Debt Securities is applicable to the entity? No
There has been no default.



Financial Results Ind-AS

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-07-2026 01-04-2026
B Date of end of reporting period 30-09-2026 30-09-2026
C Whether results are audited or unaudited Unaudited Unaudited
D Nature of report standalone or consolidated Standalone Standalone
1 Income
Revenue from operations 3,48,200.00 6,35,420.00
Other income 16,460.00 28,830.00
Total income 3,64,660.00 6,64,250.00
2 Expenses
(a) Cost of materials consumed 98,650.00 1,84,800.00
(b) Purchases of stock-in-trade 13,260.00 33,080.00
(c) Changes in inventories of finished goods, work-in-progress and stock-in-trade (5,850.00) (27,520.00)
(d) Employee benefit expense 55,440.00 1,11,580.00
(e) Finance costs 10,140.00 20,450.00
(f) Depreciation, depletion and amortisation expense 15,540.00 30,730.00
(f) Other Expenses
1 Other expenses 94,870.00 1,86,900.00
2 Net (gain) on foreign currency transactions (13,790.00) (17,740.00)
Total other expenses 81,080.00 1,69,160.00
Total expenses 2,68,260.00 5,22,280.00
3 Total profit before exceptional items and tax 96,400.00 1,41,970.00
4 Exceptional items (190.00) (190.00)
5 Total profit before tax 96,210.00 1,41,780.00
6 Tax expense
7 Current tax 24,920.00 36,690.00
8 Deferred tax (160.00) (320.00)
9 Total tax expenses 24,760.00 36,370.00
10 Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement 0.00 0.00
11 Net Profit Loss for the period from continuing operations 71,450.00 1,05,410.00
12 Profit (loss) from discontinued operations before tax 0.00 0.00
13 Tax expense of discontinued operations 0.00 0.00
14 Net profit (loss) from discontinued operation after tax 0.00 0.00
15 Share of profit (loss) of associates and joint ventures accounted for using equity method 0.00 0.00
16 Total profit (loss) for period 71,450.00 1,05,410.00
17 Other comprehensive income net of taxes (1,830.00) 270.00
18 Total Comprehensive Income for the period 69,620.00 1,05,680.00
19 Total profit or loss, attributable to
Profit or loss, attributable to owners of parent
Total profit or loss, attributable to non-controlling interests
20 Total Comprehensive income for the period attributable to
Comprehensive income for the period attributable to owners of parent
Total comprehensive income for the period attributable to owners of parent non-controlling interests
21 Details of equity share capital
Paid-up equity share capital 9,980.00 9,980.00
Face value of equity share capital 1 1
27 Details of debt securities
22 Reserves excluding revaluation reserve
23 Earnings per share
i Earnings per equity share for continuing operations
Basic earnings (loss) per share from continuing operations 7.15 10.53
Diluted earnings (loss) per share from continuing operations 7.15 10.53
ii Earnings per equity share for discontinued operations
Basic earnings (loss) per share from discontinued operations 0 0
Diluted earnings (loss) per share from discontinued operations 0 0
ii Earnings per equity share
Basic earnings (loss) per share from continuing and discontinued operations 7.15 10.53
Diluted earnings (loss) per share from continuing and discontinued operations 7.15 10.53
24 Debt equity ratio
25 Debt service coverage ratio
26 Interest service coverage ratio
27 Disclosure of notes on financial results



Remarks

Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio


Statement of Asset and Liabilities

Amount in (Lakhs)

Particulars Year ended (dd-mm-yyyy)
Date of start of reporting period 01-04-2026
Date of end of reporting period 30-09-2026
Whether results are audited or unaudited Unaudited
Nature of report standalone or consolidated Standalone
Assets
1 Non-current assets
Property, plant and equipment 4,95,430.00
Capital work-in-progress 94,980.00
Investment property 0.00
Goodwill 0.00
Other intangible assets 6,240.00
Intangible assets under development 0.00
Biological assets other than bearer plants 0.00
Investments accounted for using equity method 0.00
Non-current financial assets
Non-current investments 9,87,390.00
Trade receivables, non-current 0.00
Loans, non-current 4,37,320.00
Other non-current financial assets
1 Other current financial assets 1,270.00
Total of other non-current financial assets 1,270.00
Total non-current financial assets 14,25,980.00
Deferred tax assets (net)
Other non-current assets
1 Other non-current assets 39,310.00
2 Assets for Current tax (Net) 6,170.00
Total of other non-current assets 45,480.00
Total non-current assets 20,68,110.00
2 Current assets
Inventories 2,73,160.00
Current financial asset
Current investments 1,07,580.00
Trade receivables, current 7,34,410.00
Cash and cash equivalents 16,800.00
Bank balance other than cash and cash equivalents 47,760.00
Loans, current 5,160.00
Other current financial assets
Total of other current financial assets 25,280.00
Total current financial assets 9,36,990.00
Current tax assets (net) 0.00
Other current assets
1 Other current assets 57,850.00
Total of other current assets 57,850.00
Total current assets 12,68,000.00
3 Non-current assets classified as held for sale 0.00
4 Regulatory deferral account debit balances and related deferred tax Assets 0.00
Total assets 33,36,110.00
Equity and liabilities
1 Equity
Equity attributable to owners of parent
Equity share capital 9,980.00
Other equity 23,42,260.00
Total equity attributable to owners of parent 23,52,240.00
Non controlling interest
Total equity 23,52,240.00
2 Liabilities
Non-current liabilities
Non-current financial liabilities
Borrowings, non-current 4,28,130.00
Trade payables, non-current
(A) Total outstanding dues of micro enterprises and small enterprises 0.00
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 0.00
Total Trade payable 0.00
Other non-current financial liabilities
1 Lease liabilities 980.00
2 Other financial liabilities 3,640.00
Total of other non-current financial liabilities 4,620.00
Total non-current financial liabilities 4,32,750.00
Provisions, non-current 26,980.00
Deferred tax liabilities (net) 7,380.00
Deferred government grants, Non-current 0.00
Other non-current liabilities
Total of other non-current liabilities
Total non-current liabilities 4,67,110.00
Current liabilities
Current financial liabilities
Borrowings, current 2,67,900.00
Trade payables, current
(A) Total outstanding dues of micro enterprises and small enterprises 7,870.00
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 1,53,080.00
Total Trade payable 1,60,950.00
Other current financial liabilities
1 Lease liabilities 90.00
2 Other financial liabilities 36,240.00
Total of other current financial liabilities 36,330.00
Total current financial liabilities 4,65,180.00
Other current liabilities 21,230.00
1 Other current liabilities 21,230.00
Total of other current liabilities 21,230.00
Provisions, current 23,590.00
Current tax liabilities (Net) 6,760.00
Deferred government grants, Current 0.00
Total current liabilities 5,16,760.00
3 Liabilities directly associated with assets in disposal group classified as held for sale
4 Regulatory deferral account credit balances and related deferred tax liability
Total liabilities 9,83,870.00
Total equity and liabilites 33,36,110.00
Disclosure of notes on assets and liabilities



Format for Reporting Segment wise Revenue, Results and Capital Employed along with the company results

Amount in (Lakhs)

Particulars 3 months/ 6 month ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period 01-07-2026 01-04-2026
Date of end of reporting period 30-09-2026 30-09-2026
Whether results are audited or unaudited Unaudited Unaudited
Nature of report standalone or consolidated Standalone Standalone
1 Segment Revenue (Income)
(net sale/income from each segment should be disclosed)
Total Segment Revenue
Less: Inter segment revenue
Revenue from operations
2 Segment Result
Profit (+) / Loss (-) before tax and interest from each segment
Total Profit before tax
i. Finance cost
ii. Other Unallocable Expenditure net off Unallocable income
Profit before tax
3 (Segment Asset - Segment Liabilities)
Segment Asset
Total Segment Asset
Un-allocable Assets null null
Net Segment Asset null null
4 Segment Liabilities
Segment Liabilities
Total Segment Liabilities
Un-allocable Liabilities null null
Net Segment Liabilities null null
Disclosure of notes on segments



Other Comprehensive Income

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-07-2026 01-04-2026
B Date of end of reporting period 30-09-2026 30-09-2026
C Whether results are audited or unaudited Unaudited Unaudited
D Nature of report standalone or consolidated Standalone Standalone
Other comprehensive income [Abstract]
1 Amount of items that will not be reclassified to profit and loss
Total Amount of items that will not be reclassified to profit and loss
2 Income tax relating to items that will not be reclassified to profit or loss 2,160.00 30.00
3 Amount of items that will be reclassified to profit and loss
Total Amount of items that will be reclassified to profit and loss
4 Income tax relating to items that will be reclassified to profit or loss (330.00) (300.00)
5 Total Other comprehensive income (1,830.00) 270.00



Cash flow statement, indirect

Amount in (Lakhs)

Particulars Year ended (dd-mm-yyyy)
A Date of start of reporting period 01-04-2026
B Date of end of reporting period 30-09-2026
C Whether results are audited or unaudited Unaudited
D Nature of report standalone or consolidated Standalone
Statement of cash flows
Cash flows from used in operating activities
Profit before tax 1,41,780.00
Adjustments for reconcile profit (loss)
Adjustments for finance costs 20,310.00
Adjustments for decrease (increase) in inventories (59,110.00)
Adjustments for decrease (increase) in trade receivables, current 82,160.00
Adjustments for decrease (increase) in trade receivables, non-current 0.00
Adjustments for decrease (increase) in other current assets (7,160.00)
Adjustments for decrease (increase) in other non-current assets 0.00
Adjustments for other financial assets, non-current 0.00
Adjustments for other financial assets, current 0.00
Adjustments for other bank balances 0.00
Adjustments for increase (decrease) in trade payables, current 6,020.00
Adjustments for increase (decrease) in trade payables, non-current 0.00
Adjustments for increase (decrease) in other current liabilities (1,370.00)
Adjustments for increase (decrease) in other non-current liabilities 0.00
Adjustments for depreciation and amortisation expense 30,730.00
Adjustments for impairment loss reversal of impairment loss recognised in profit or loss 0.00
Adjustments for provisions, current 7,400.00
Adjustments for provisions, non-current 2,940.00
Adjustments for other financial liabilities, current 0.00
Adjustments for other financial liabilities, non-current 0.00
Adjustments for unrealised foreign exchange losses gains 29,360.00
Adjustments for dividend income 2,320.00
Adjustments for interest income 25,160.00
Adjustments for share-based payments 0.00
Adjustments for fair value losses (gains) 1,850.00
Adjustments for undistributed profits of associates 0.00
Other adjustments for which cash effects are investing or financing cash flow 70.00
Other adjustments to reconcile profit (loss) 0.00
Other adjustments for non-cash items 20.00
Share of profit and loss from partnership firm or association of persons or limited liability partnerships 0.00
Total adjustments for reconcile profit (loss) 85,740.00
Net cash flows from (used in) operations 2,27,520.00
Dividends received 0.00
Interest paid 0.00
Interest received 0.00
Income taxes paid (refund) 52,460.00
Other inflows (outflows) of cash 0.00
Net cash flows from (used in) operating activities 1,75,060.00
Cash flows from used in investing activities
Cash flows from losing control of subsidiaries or other businesses 0.00
Cash flows used in obtaining control of subsidiaries or other businesses 30,060.00
Other cash receipts from sales of equity or debt instruments of other entities 3,250.00
Other cash payments to acquire equity or debt instruments of other entities 590.00
Other cash receipts from sales of interests in joint ventures 0.00
Other cash payments to acquire interests in joint ventures 0.00
Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships 0.00
Cash payment for investment in partnership firm or association of persons or limited liability partnerships 0.00
Proceeds from sales of property, plant and equipment 520.00
Purchase of property, plant and equipment 69,150.00
Proceeds from sales of investment property 0.00
Purchase of investment property 0.00
Proceeds from sales of intangible assets 0.00
Purchase of intangible assets 0.00
Proceeds from sales of intangible assets under development 0.00
Purchase of intangible assets under development 0.00
Proceeds from sales of goodwill 0.00
Purchase of goodwill 0.00
Proceeds from biological assets other than bearer plants 0.00
Purchase of biological assets other than bearer plants 0.00
Proceeds from government grants 0.00
Proceeds from sales of other long-term assets 0.00
Purchase of other long-term assets 0.00
Cash advances and loans made to other parties 10,190.00
Cash receipts from repayment of advances and loans made to other parties 10,230.00
Cash payments for future contracts, forward contracts, option contracts and swap contracts 0.00
Cash receipts from future contracts, forward contracts, option contracts and swap contracts 0.00
Dividends received 2,320.00
Interest received 17,540.00
Income taxes paid (refund) 0.00
Other inflows (outflows) of cash 74,020.00
Net cash flows from (used in) investing activities (2,110.00)
Cash flows from used in financing activities
Proceeds from changes in ownership interests in subsidiaries 0.00
Payments from changes in ownership interests in subsidiaries 0.00
Proceeds from issuing shares 0.00
Proceeds from issuing other equity instruments 0.00
Payments to acquire or redeem entity's shares 1,10,630.00
Payments of other equity instruments 0.00
Proceeds from exercise of stock options 0.00
Proceeds from issuing debentures notes bonds etc 0.00
Proceeds from borrowings 9,580.00
Repayments of borrowings 57,160.00
Payments of lease liabilities 100.00
Dividends paid 20,560.00
Interest paid 9,980.00
Income taxes paid (refund) 0.00
Other inflows (outflows) of cash 0.00
Net cash flows from (used in) financing activities (1,88,850.00)
Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes (15,900.00)
Effect of exchange rate changes on cash and cash equivalents
Effect of exchange rate changes on cash and cash equivalents 0.00
Net increase (decrease) in cash and cash equivalents (15,900.00)
Cash and cash equivalents cash flow statement at beginning of period 32,700.00
Cash and cash equivalents cash flow statement at end of period 16,800.00





Amount in (Lakhs)

Format for Disclosure of Related Party Transactions (applicable only for half-yearly filings i.e., 2nd and 4th quarter)

Sr No. Additional disclosure of related party transactions - applicable only in case the related party transaction relates to loans, inter-corporate deposits, advances or investments made or given by the listed entity/subsidiary. These details need to be disclosed only once, during the reporting period when such transaction was undertaken.
Details of the party (listed entity/subsidiary) entering into the transaction Details of the counterparty Type of related party transaction Details of other related party transaction Value of the related party transaction as approved by the audit committee Remarks on approval by audit committee Value of the related party transaction ratified by the audit committee Date of Audit Committee Meeting where the ratification was approved Value of transaction during the reporting period In case monies are due to either party as a result of the transaction In case any financial indebtedness is incurred to make or give loans, inter-corporate deposits, advances or investments Details of the loans, inter-corporate deposits, advances or investments Notes
Name PAN Name PAN Relationship of the counterparty with the listed entity or its subsidiary Opening balance Closing balance Nature of indebtedness (loan/ issuance of debt/ any other etc.) Details of other indebtedness Cost Tenure Nature (loan/ advance/ intercorporate deposit/ investment ) Interest Rate (%) Tenure Secured/ unsecured Purpose for which the funds will be utilised by the ultimate recipient of funds (endusage)
1 Zydus Lifesciences Limited Zydus Wellness Products Limited Subsidiary Company Purchase of goods or services 5.20 Amount as approved by the Audit Committee. 5.20 0.00 0.00
2 Zydus Lifesciences Limited Zydus Pharmaceuticals Limited Subsidiary Company Purchase of goods or services 0.00 Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. 23,083.30 0.00 0.00
3 Zydus Lifesciences Limited Zydus VTEC Limited Subsidiary Company Sale of goods or services 0.00 Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. 25.60 0.00 0.00
4 Zydus Lifesciences Limited Zydus Healthcare Limited Subsidiary Company Purchase of goods or services 0.00 Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. 1,060.70 0.00 0.00
5 Zydus Lifesciences Limited Zydus Healthcare S.A. (Pty) Ltd Subsidiary Company Purchase of goods or services 0.00 Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. (11.40) 0.00 0.00
6 Zydus Lifesciences Limited Zydus Nikkho Farmaceutica Ltda. Subsidiary Company Purchase of goods or services 0.00 Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. 0.90 0.00 0.00
7 Zydus Lifesciences Limited Zydus Healthcare (USA) LLC Subsidiary Company Purchase of goods or services 0.00 Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. 73.40 0.00 0.00
8 Zydus Lifesciences Limited Zydus Animal Health and Investments Limited Subsidiary Company Purchase of goods or services 0.00 Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. 28.70 0.00 0.00
9 Zydus Lifesciences Limited Sterling Biotech Limited Joint Ventures Purchase of goods or services 186.40 Amount as approved by the Audit Committee. 186.40 0.00 0.00
10 Zydus Lifesciences Limited Cadmach Machinery Company Private Limited Enterprises significantly influenced by Directors and/ or their relatives Purchase of goods or services 35.40 Amount as approved by the Audit Committee. 35.40 0.00 0.00
11 Zydus Lifesciences Limited Oneiro Chemicals Private Limited Enterprises significantly influenced by Directors and/ or their relatives Purchase of goods or services 3,517.90 Amount as approved by the Audit Committee. 3,517.90 0.00 0.00
12 Zydus Lifesciences Limited Zydus VTEC Limited Subsidiary Company Purchase of fixed assets 0.00 Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. 18.80 0.00 0.00
13 Zydus Lifesciences Limited Zydus Wellness Products Limited Subsidiary Company Purchase of goods or services 0.50 Amount as approved by the Audit Committee. 0.50 0.00 0.00
14 Zydus Lifesciences Limited German Remedies Pharma Private Limited Subsidiary Company Purchase of goods or services 0.00 Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. 29.80 0.00 0.00
15 Zydus Lifesciences Limited Zydus Pharmaceuticals Limited Subsidiary Company Purchase of goods or services 0.00 Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. 1,720.00 0.00 0.00
16 Zydus Lifesciences Limited Zydus Healthcare Limited Subsidiary Company Purchase of goods or services 0.00 Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. 678.10 0.00 0.00
17 Zydus Lifesciences Limited Zydus Medtech France SAS Subsidiary Company Sale of goods or services 0.00 Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. 1,003.50 0.00 0.00
18 Zydus Lifesciences Limited Zydus Medtech France SAS Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 1,468.70 2,472.30
19 Zydus Lifesciences Limited LM Manufacturing Limited Subsidiary Company Purchase of goods or services 0.00 Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. 6.50 0.00 0.00
20 Zydus Lifesciences Limited LM Manufacturing Limited Subsidiary Company Purchase of goods or services 0.00 Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. 0.40 0.00 0.00
21 Zydus Lifesciences Limited LM Manufacturing Limited Subsidiary Company Sale of goods or services 0.00 Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. (35.80) 0.00 0.00
22 Zydus Lifesciences Limited LM Manufacturing Limited Subsidiary Company Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 203.40 212.50
23 Zydus Lifesciences Limited LM Manufacturing Limited Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 63.50 27.90
24 Zydus Lifesciences Limited Vitely Corp Pvt Ltd (Formerly Known Vitely Bio LLP) Enterprises significantly influenced by Directors and/ or their relatives Purchase of goods or services 58.70 Amount as approved by the Audit Committee. 58.70 0.00 0.00
25 Zydus Lifesciences Limited Zydus Hospitals and Healthcare Research Private Limited Enterprises significantly influenced by Directors and/ or their relatives Purchase of goods or services 3.60 Amount as approved by the Audit Committee. 3.60 0.00 0.00
26 Zydus Lifesciences Limited Cadmach Machinery Company Private Limited Enterprises significantly influenced by Directors and/ or their relatives Purchase of goods or services 31.30 Amount as approved by the Audit Committee. 31.30 0.00 0.00
27 Zydus Lifesciences Limited Mukesh M. Patel & Co., Proprietorship Firm Enterprises significantly influenced by Directors and/ or their relatives Purchase of goods or services 55.00 Amount as approved by the Audit Committee. 55.00 0.00 0.00
28 Zydus Lifesciences Limited International Tax & Investment Consultants-Proprietorship Firm Enterprises significantly influenced by Directors and/ or their relatives Purchase of goods or services 34.00 Amount as approved by the Audit Committee. 34.00 0.00 0.00
29 Zydus Lifesciences Limited Violio Healthcare Limited Subsidiary Company Investment 0.00 Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. 990.00 0.00 990.00 Investment 0 N.A Unsecured Business Purpose Textual Information(1)
30 Zydus Lifesciences Limited Apollo Healthco Limited Enterprises significantly influenced by Directors and/ or their relatives Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 2.20 0.00
31 Zydus Lifesciences Limited Apollo Healthco Limited Enterprises significantly influenced by Directors and/ or their relatives Purchase of goods or services 78.60 Amount as approved by the Audit Committee. 78.60 0.00 0.00
32 Zydus Lifesciences Limited Zydus Infrastructure Private Limited Enterprises significantly influenced by Directors and/ or their relatives Purchase of goods or services 512.80 Amount as approved by the Audit Committee. 512.80 0.00 0.00
33 Zydus Lifesciences Limited Zydus Pharmaceuticals (USA) Inc. Subsidiary Company Any other transaction Reimbursement of Expenses paid 0.00 Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. 5,372.50 0.00 0.00
34 Zydus Lifesciences Limited Zydus Healthcare (USA) LLC Subsidiary Company Any other transaction Reimbursement of Expenses paid 0.00 Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. 396.00 0.00 0.00
35 Zydus Lifesciences Limited Zydus Healthcare S.A. (Pty) Ltd Subsidiary Company Any other transaction Reimbursement of Expenses paid 0.00 Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. 498.40 0.00 0.00
36 Zydus Lifesciences Limited Zydus Pharmaceuticals Mexico SA De CV Subsidiary Company Any other transaction Reimbursement of Expenses paid 0.00 Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. 68.20 0.00 0.00
37 Zydus Lifesciences Limited Zydus France, SAS Subsidiary Company Any other transaction Reimbursement of Expenses paid 0.00 Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. 1,373.00 0.00 0.00
38 Zydus Lifesciences Limited Laboratorios Combix S.L. Subsidiary Company Any other transaction Reimbursement of Expenses paid 0.00 Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. 468.20 0.00 0.00
39 Zydus Lifesciences Limited Zydus Lanka (Private) Limited Subsidiary Company Any other transaction Reimbursement of Expenses paid 0.00 Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. 45.10 0.00 0.00
40 Zydus Lifesciences Limited Zydus Nikkho Farmaceutica Ltda. Subsidiary Company Any other transaction Reimbursement of Expenses paid 0.00 Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. 38.20 0.00 0.00
41 Zydus Lifesciences Limited Zydus Pharmaceuticals Limited Subsidiary Company Loan 0.00 Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. 10,190.00 0.00 0.00 Loan 0.800 5 Year Unsecured Business Purpose Textual Information(2)
42 Zydus Lifesciences Limited Zydus Pharmaceuticals Limited Subsidiary Company Interest received 0.00 N.A. 746.50 0.00 0.00
43 Zydus Lifesciences Limited Zydus Pharmaceuticals Limited Subsidiary Company Any other transaction Outstanding Receivables - Loans 0.00 N.A. 0.00 14,960.80 25,671.90
44 Zydus Lifesciences Limited Zydus Pharmaceuticals UK Ltd. Subsidiary Company Any other transaction Reimbursement of Expenses paid 0.00 Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. 785.60 0.00 0.00
45 Zydus Lifesciences Limited Zydus Hospira Oncology Private Limited Joint Ventures Any other transaction Reimbursement of Expenses Recovered 70.30 Amount as approved by the Audit Committee. 70.30 0.00 0.00
46 Zydus Lifesciences Limited Zydus Infrastructure Private Limited Enterprises significantly influenced by Directors and/ or their relatives Any other transaction Reimbursement of Expenses paid 0.20 Amount as approved by the Audit Committee. 0.20 0.00 0.00
47 Zydus Lifesciences Limited Zydus Animal Health and Investments Limited Subsidiary Company Sale of goods or services 0.00 Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. 2.00 0.00 0.00
48 Zydus Lifesciences Limited Zydus Pharmaceuticals Limited Subsidiary Company Sale of goods or services 0.00 Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. 11,701.40 0.00 0.00
49 Zydus Lifesciences Limited Zydus Healthcare Limited Subsidiary Company Sale of goods or services 0.00 Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. 6,645.50 0.00 0.00
50 Zydus Lifesciences Limited Zydus Pharmaceuticals (USA) Inc. Subsidiary Company Sale of goods or services 0.00 Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. 2,70,155.60 0.00 0.00
51 Zydus Lifesciences Limited Viona Pharmaceuticals INC Subsidiary Company Sale of goods or services 0.00 Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. 36,842.40 0.00 0.00
52 Zydus Lifesciences Limited Zydus Healthcare Philippines Inc. Subsidiary Company Sale of goods or services 0.00 Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. 4,872.80 0.00 0.00
53 Zydus Lifesciences Limited Alidac Healthcare (Myanmar) Limited Subsidiary Company Sale of goods or services 0.00 Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. 2,378.10 0.00 0.00
54 Zydus Lifesciences Limited Zydus Healthcare S.A. (Pty) Ltd Subsidiary Company Sale of goods or services 0.00 Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. 5,237.60 0.00 0.00
55 Zydus Lifesciences Limited Zydus Pharmaceuticals Mexico SA De CV Subsidiary Company Sale of goods or services 0.00 Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. 9,292.20 0.00 0.00
56 Zydus Lifesciences Limited Zydus Nikkho Farmaceutica Ltda. Subsidiary Company Sale of goods or services 0.00 Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. 4,340.50 0.00 0.00
57 Zydus Lifesciences Limited Zydus France, SAS Subsidiary Company Sale of goods or services 0.00 Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. 5,625.50 0.00 0.00
58 Zydus Lifesciences Limited Laboratorios Combix S.L. Subsidiary Company Sale of goods or services 0.00 Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. 3,038.10 0.00 0.00
59 Zydus Lifesciences Limited Zydus Worldwide DMCC Subsidiary Company Sale of goods or services 0.00 Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. 2,256.70 0.00 0.00
60 Zydus Lifesciences Limited Zydus Lifesciences Global FZE [UAE] Subsidiary Company Sale of goods or services 0.00 Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. 19,307.00 0.00 0.00
61 Zydus Lifesciences Limited Zydus Takeda Healthcare Private Limited Joint Ventures Sale of goods or services 577.50 Amount as approved by the Audit Committee. 577.50 0.00 0.00
62 Zydus Lifesciences Limited Zydus Hospitals and Healthcare Research Private Limited Enterprises significantly influenced by Directors and/ or their relatives Sale of goods or services 277.10 Amount as approved by the Audit Committee. 277.10 0.00 0.00
63 Zydus Lifesciences Limited Zydus Hospitals and Healthcare Research Private Limited Enterprises significantly influenced by Directors and/ or their relatives Sale of goods or services 20.70 Amount as approved by the Audit Committee. 20.70 0.00 0.00
64 Zydus Lifesciences Limited Zydus Healthcare Limited Subsidiary Company Sale of fixed assets 0.00 Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. 40.50 0.00 0.00
65 Zydus Lifesciences Limited Alidac Healthcare (Myanmar) Limited Subsidiary Company Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 18.70 18.10
66 Zydus Lifesciences Limited Alidac Healthcare (Myanmar) Limited Subsidiary Company Sale of goods or services 0.00 Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. 498.30 0.00 0.00
67 Zydus Lifesciences Limited Zydus Animal Health and Investments Limited Subsidiary Company Sale of fixed assets 0.00 Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. 0.10 0.00 0.00
68 Zydus Lifesciences Limited Zydus Wellness Limited Subsidiary Company Sale of goods or services 48.00 Amount as approved by the Audit Committee. 48.00 0.00 0.00
69 Zydus Lifesciences Limited Zydus Wellness Products Limited Subsidiary Company Sale of goods or services 130.20 Amount as approved by the Audit Committee. 130.20 0.00 0.00
70 Zydus Lifesciences Limited German Remedies Pharma Private Limited Subsidiary Company Sale of goods or services 0.00 Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. 41.50 0.00 0.00
71 Zydus Lifesciences Limited Zydus Animal Health and Investments Limited Subsidiary Company Sale of goods or services 0.00 Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. 58.20 0.00 0.00
72 Zydus Lifesciences Limited Zydus Pharmaceuticals Limited Subsidiary Company Sale of goods or services 0.00 Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. 20.30 0.00 0.00
73 Zydus Lifesciences Limited Zydus VTEC Limited Subsidiary Company Sale of goods or services 0.00 Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. 438.40 0.00 0.00
74 Zydus Lifesciences Limited Zydus Healthcare Limited Subsidiary Company Sale of goods or services 0.00 Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. 3,144.40 0.00 0.00
75 Zydus Lifesciences Limited Zydus Pharmaceuticals (USA) Inc. Subsidiary Company Sale of goods or services 0.00 Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. 172.00 0.00 0.00
76 Zydus Lifesciences Limited Sentynl Therapeutics Inc. Subsidiary Company Sale of goods or services 0.00 Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. 167.30 0.00 0.00
77 Zydus Lifesciences Limited Viona Pharmaceuticals INC Subsidiary Company Sale of goods or services 0.00 Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. 73.70 0.00 0.00
78 Zydus Lifesciences Limited Zydus Therapeutics INC Subsidiary Company Sale of goods or services 0.00 Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. 449.70 0.00 0.00
79 Zydus Lifesciences Limited Zydus Pharmaceuticals UK Ltd. Subsidiary Company Sale of goods or services 0.00 Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. 264.30 0.00 0.00
80 Zydus Lifesciences Limited Zydus Lifesciences Global FZE [UAE] Subsidiary Company Sale of goods or services 0.00 Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. 2,296.50 0.00 0.00
81 Zydus Lifesciences Limited Zydus Medtech Private Limited Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 12.70 11.60
82 Zydus Lifesciences Limited Zydus Medtech Private Limited Subsidiary Company Investment 0.00 Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. 10,000.00 0.00 23,600.00 Investment 0 N.A Unsecured Business Purpose Textual Information(3)
83 Zydus Lifesciences Limited Zydus Medtech Private Limited Subsidiary Company Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 0.00 17.80
84 Zydus Lifesciences Limited Zydus Medtech Private Limited Subsidiary Company Sale of goods or services 0.00 Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. 11.00 0.00 0.00
85 Zydus Lifesciences Limited Zydus Animal Health and Investments Limited Subsidiary Company Any other transaction Reimbursement of Expenses Recovered 0.00 Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. 276.90 0.00 0.00
86 Zydus Lifesciences Limited Zydus Lifesciences Global FZE [UAE] Subsidiary Company Interest received 0.00 N.A. 1,026.30 0.00 0.00
87 Zydus Lifesciences Limited Zydus Lifesciences Global FZE [UAE] Subsidiary Company Any other transaction Outstanding Receivables - Loans 0.00 N.A. 0.00 34,232.10 34,577.30
88 Zydus Lifesciences Limited Zydus Lifesciences Global FZE [UAE] Subsidiary Company Any other transaction Reimbursement of Expenses Recovered 0.00 Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. 513.40 0.00 0.00
89 Zydus Lifesciences Limited Zydus Wellness Limited Subsidiary Company Any other transaction Reimbursement of Expenses Recovered 11.50 Amount as approved by the Audit Committee. 11.50 0.00 0.00
90 Zydus Lifesciences Limited Zydus Wellness Products Limited Subsidiary Company Any other transaction Reimbursement of Expenses paid 8.00 Amount as approved by the Audit Committee. 8.00 0.00 0.00
91 Zydus Lifesciences Limited Zydus Wellness Products Limited Subsidiary Company Any other transaction Reimbursement of Expenses Recovered 115.60 Amount as approved by the Audit Committee. 115.60 0.00 0.00
92 Zydus Lifesciences Limited Zydus Healthcare Limited Subsidiary Company Any other transaction Reimbursement of Expenses Recovered 0.00 Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. 51.30 0.00 0.00
93 Zydus Lifesciences Limited Mr. Pankaj R. Patel Key Managerial Personnel Any other transaction Director Sitting Fees 0.00 N.A. 5.00 0.00 0.00
94 Zydus Lifesciences Limited Dr. Sharvil P. Patel Key Managerial Personnel Remuneration 2,250.00 Amount as approved by the Audit Committee. 2,250.00 0.00 0.00
95 Zydus Lifesciences Limited Mr. Tushar D. Shroff Key Managerial Personnel Remuneration 196.60 Amount as approved by the Audit Committee. 196.60 0.00 0.00
96 Zydus Lifesciences Limited Mr. Dhaval N. Soni Key Managerial Personnel Remuneration 32.90 Amount as approved by the Audit Committee. 32.90 0.00 0.00
97 Zydus Lifesciences Limited Dialforhealth Unity Limited Subsidiary Company Interest received 0.00 N.A. 1.00 0.00 0.00
98 Zydus Lifesciences Limited Zydus International Private Limited Subsidiary Company Interest received 0.00 N.A. 2,761.20 0.00 0.00
99 Zydus Lifesciences Limited Zydus Pharmaceuticals (USA) Inc. Subsidiary Company Interest received 0.00 N.A. 2,259.60 0.00 0.00
100 Zydus Lifesciences Limited Sentynl Therapeutics Inc. Subsidiary Company Interest received 0.00 N.A. 3,104.20 0.00 0.00
101 Zydus Lifesciences Limited Zydus Worldwide DMCC Subsidiary Company Interest received 0.00 N.A. 499.90 0.00 0.00
102 Zydus Lifesciences Limited Zydus Pharmaceuticals UK Ltd. Subsidiary Company Sale of goods or services 0.00 Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. 365.20 0.00 0.00
103 Zydus Lifesciences Limited Zydus Pharmaceuticals UK Ltd. Subsidiary Company Interest received 0.00 N.A. 304.10 0.00 0.00
104 Zydus Lifesciences Limited German Remedies Pharma Private Limited Subsidiary Company Interest paid 0.00 N.A. 133.90 0.00 0.00
105 Zydus Lifesciences Limited Zydus Animal Health and Investments Limited Subsidiary Company Interest paid 0.00 N.A. 2,755.50 0.00 0.00
106 Zydus Lifesciences Limited Zydus Healthcare Limited Subsidiary Company Interest paid 0.00 N.A. 10,803.30 0.00 0.00
107 Zydus Lifesciences Limited Zydus Foundation Enterprises significantly influenced by Directors and/ or their relatives Any other transaction Advance for CSR 0.00 N.A. 126.70 0.00 0.00
108 Zydus Lifesciences Limited Zydus Foundation Enterprises significantly influenced by Directors and/ or their relatives Any other transaction Corporate Social Responsibility (CSR) Expenses 0.00 N.A. 431.40 0.00 0.00
109 Zydus Lifesciences Limited Zydus Pharmaceuticals Limited Subsidiary Company Investment 0.00 Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. 0.00 99,000.00 0.00
110 Zydus Lifesciences Limited Zydus Pharmaceuticals Canada Inc. Subsidiary Company Any other transaction Reimbursement of Expenses paid 0.00 Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. 1,162.70 0.00 0.00
111 Zydus Lifesciences Limited Zydus Pharmaceuticals Canada Inc. Subsidiary Company Any other transaction Reimbursement of Expenses Recovered 0.00 Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. 67.30 0.00 0.00
112 Zydus Lifesciences Limited Zydus Pharmaceuticals Canada Inc. Subsidiary Company Sale of goods or services 0.00 Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. 718.00 0.00 0.00
113 Zydus Lifesciences Limited Zydus Pharmaceuticals Canada Inc. Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 201.10 728.90
114 Zydus Lifesciences Limited Zydus Pharmaceuticals Canada Inc. Subsidiary Company Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 279.90 419.20
115 Zydus Lifesciences Limited ZyVet Animal Health Inc Subsidiary Company Sale of goods or services 0.00 Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. 5.40 0.00 0.00
116 Zydus Lifesciences Limited ZyVet Animal Health Inc Subsidiary Company Sale of goods or services 0.00 Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. 26.00 0.00 0.00
117 Zydus Lifesciences Limited ZyVet Animal Health Inc Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 0.00 31.40
118 Zydus Lifesciences Limited Zynext Ventures Pte. Ltd. Subsidiary Company Investment 0.00 Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. 19,069.00 13,525.70 32,594.70 Investment 0 N.A Unsecured Business Purpose Textual Information(4)
119 Zydus Lifesciences Limited Zydus Pharmaceuticals UK Ltd. Subsidiary Company Loan 0.00 Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. 10,231.70 0.00 0.00
120 Zydus Lifesciences Limited Zydus Healthcare Limited Subsidiary Company Loan 0.00 Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. 52,500.00 0.00 0.00
121 Zydus Lifesciences Limited Zydus Animal Health and Investments Limited Subsidiary Company Loan 0.00 Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. 4,660.00 0.00 0.00
122 Zydus Lifesciences Limited Cadila Healthcare Ltd. Managerial Cadre EPF Post Employment Benefit Plans Any other transaction Contributions during the year [includes Employee's share and contribution] 3,556.60 Amount as approved by the Audit Committee. 3,556.60 0.00 0.00
123 Zydus Lifesciences Limited Cadila Healthcare Limited Employees Group Gratuity Scheme Post Employment Benefit Plans Any other transaction Contributions during the year [includes Employee's share and contribution] 163.00 Amount as approved by the Audit Committee. 163.00 0.00 0.00
124 Zydus Lifesciences Limited Zylidac Bio LLC, USA Subsidiary Company Purchase of goods or services 0.00 Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. 11,435.90 0.00 0.00
125 Zydus Lifesciences Limited Zylidac Bio LLC, USA Subsidiary Company Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 5,158.10 16,593.90
126 Zydus Lifesciences Limited Zydus Animal Health and Investments Limited Subsidiary Company Any other transaction Outstanding Payables - Loans 0.00 N.A. 0.00 90,766.30 86,298.10
127 Zydus Lifesciences Limited Zydus Healthcare Limited Subsidiary Company Any other transaction Outstanding Payables - Loans 0.00 N.A. 0.00 3,92,441.70 3,48,998.90
128 Zydus Lifesciences Limited German Remedies Pharma Private Limited Subsidiary Company Any other transaction Outstanding Payables - Loans 0.00 N.A. 0.00 4,119.40 4,120.50
129 Zydus Lifesciences Limited Zydus Pharmaceuticals Limited Subsidiary Company Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 5,890.40 298.70
130 Zydus Lifesciences Limited Zydus VTEC Limited Subsidiary Company Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 170.70 103.80
131 Zydus Lifesciences Limited Zydus Healthcare Limited Subsidiary Company Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 0.00 1,884.80
132 Zydus Lifesciences Limited Zydus Pharmaceuticals (USA) Inc. Subsidiary Company Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 6,397.70 8,214.80
133 Zydus Lifesciences Limited Zydus Healthcare (USA) LLC Subsidiary Company Investment 0.00 Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. 0.00 0.00 0.00
134 Zydus Lifesciences Limited Zydus Healthcare (USA) LLC Subsidiary Company Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 626.60 440.40
135 Zydus Lifesciences Limited Viona Pharmaceuticals INC Subsidiary Company Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 895.90 905.10
136 Zydus Lifesciences Limited Zydus Healthcare S.A. (Pty) Ltd Subsidiary Company Sale of goods or services 0.00 Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. 9.60 0.00 0.00
137 Zydus Lifesciences Limited Zydus Healthcare S.A. (Pty) Ltd Subsidiary Company Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 3,791.20 1,859.50
138 Zydus Lifesciences Limited Zydus Pharmaceuticals Mexico SA De CV Subsidiary Company Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 834.90 910.40
139 Zydus Lifesciences Limited Zydus Nikkho Farmaceutica Ltda. Subsidiary Company Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 982.10 1,031.80
140 Zydus Lifesciences Limited Zydus France, SAS Subsidiary Company Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 3,187.60 2,087.40
141 Zydus Lifesciences Limited Zydus Lanka (Private) Limited Subsidiary Company Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 3.00 45.10
142 Zydus Lifesciences Limited Zydus Lanka (Private) Limited Subsidiary Company Sale of goods or services 0.00 Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. 6.20 0.00 0.00
143 Zydus Lifesciences Limited Zydus Lanka (Private) Limited Subsidiary Company Sale of goods or services 0.00 Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. 43.10 0.00 0.00
144 Zydus Lifesciences Limited Zydus Lanka (Private) Limited Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 88.20 39.40
145 Zydus Lifesciences Limited Zydus Wellness Products Limited Subsidiary Company Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 10.40 19.80
146 Zydus Lifesciences Limited Zydus Pharmaceuticals UK Ltd. Subsidiary Company Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 1,043.20 1,662.20
147 Zydus Lifesciences Limited Sterling Biotech Limited Joint Ventures Any other transaction Capital Advances 4,700.00 Amount as approved by the Audit Committee. 4,700.00 0.00 0.00
148 Zydus Lifesciences Limited Sterling Biotech Limited Joint Ventures Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 145.30 147.80
149 Zydus Lifesciences Limited Zydus Hospira Oncology Private Limited Joint Ventures Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 24.70 10.40
150 Zydus Lifesciences Limited Zydus Hospira Oncology Private Limited Joint Ventures Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 0.00 16.10
151 Zydus Lifesciences Limited Assertio Holdings Inc. [USA] Subsidiary Company Sale of goods or services 0.00 Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. 236.70 0.00 0.00
152 Zydus Lifesciences Limited Assertio Holdings Inc. [USA] Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 0.00 237.10
153 Zydus Lifesciences Limited Vitely Corp Pvt Ltd (Formerly Known Vitely Bio LLP) Enterprises significantly influenced by Directors and/ or their relatives Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 9.80 26.80
154 Zydus Lifesciences Limited Zydus Hospitals and Healthcare Research Private Limited Enterprises significantly influenced by Directors and/ or their relatives Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 1.20 0.00
155 Zydus Lifesciences Limited Cadmach Machinery Company Private Limited Enterprises significantly influenced by Directors and/ or their relatives Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 32.70 50.20
156 Zydus Lifesciences Limited Oneiro Chemicals Private Limited Enterprises significantly influenced by Directors and/ or their relatives Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 662.90 942.40
157 Zydus Lifesciences Limited Zydus Infrastructure Private Limited Enterprises significantly influenced by Directors and/ or their relatives Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 275.20 281.10
158 Zydus Lifesciences Limited Aleta Hospitals LLP [Formerly known as Zydus Hospitals (Vadodara) LLP] Enterprises significantly influenced by Directors and/ or their relatives Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 0.00 0.00
159 Zydus Lifesciences Limited Dr. Sharvil P. Patel Key Managerial Personnel Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 2,707.50 750.10
160 Zydus Lifesciences Limited Dialforhealth Unity Limited Subsidiary Company Any other transaction Outstanding Receivables - Loans 0.00 N.A. 0.00 27.50 28.30
161 Zydus Lifesciences Limited Zydus Pharmaceuticals UK Ltd. Subsidiary Company Any other transaction Outstanding Receivables - Loans 0.00 N.A. 0.00 15,921.00 5,734.00
162 Zydus Lifesciences Limited Zydus International Private Limited Subsidiary Company Any other transaction Outstanding Receivables - Loans 0.00 N.A. 0.00 1,29,474.70 1,32,218.60
163 Zydus Lifesciences Limited Zydus Pharmaceuticals (USA) Inc. Subsidiary Company Any other transaction Outstanding Receivables - Loans 0.00 N.A. 0.00 1,04,280.00 1,05,380.00
164 Zydus Lifesciences Limited Sentynl Therapeutics Inc. Subsidiary Company Any other transaction Outstanding Receivables - Loans 0.00 N.A. 0.00 1,13,760.00 1,14,960.00
165 Zydus Lifesciences Limited Zydus Worldwide DMCC Subsidiary Company Any other transaction Outstanding Receivables - Loans 0.00 N.A. 0.00 23,416.10 23,912.30
166 Zydus Lifesciences Limited Zydus Healthcare Limited Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 3,852.00 2,438.20
167 Zydus Lifesciences Limited Zydus Wellness Limited Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 50.30 60.20
168 Zydus Lifesciences Limited Zydus Wellness Products Limited Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 140.00 282.00
169 Zydus Lifesciences Limited German Remedies Pharma Private Limited Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 124.00 61.00
170 Zydus Lifesciences Limited Zydus Animal Health and Investments Limited Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 264.40 197.80
171 Zydus Lifesciences Limited Zydus Animal Health and Investments Limited Subsidiary Company Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 96.00 173.10
172 Zydus Lifesciences Limited Zydus Pharmaceuticals Limited Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 13,141.50 17,974.80
173 Zydus Lifesciences Limited Zydus VTEC Limited Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 39.20 373.60
174 Zydus Lifesciences Limited Zydus Pharmaceuticals (USA) Inc. Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 5,90,904.80 4,46,101.10
175 Zydus Lifesciences Limited Sentynl Therapeutics Inc. Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 149.60 85.80
176 Zydus Lifesciences Limited Viona Pharmaceuticals INC Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 15,953.70 32,868.40
177 Zydus Lifesciences Limited Zydus Therapeutics INC Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 205.20 656.80
178 Zydus Lifesciences Limited Zydus Healthcare Philippines Inc. Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 2,370.50 2,799.60
179 Zydus Lifesciences Limited Alidac Healthcare (Myanmar) Limited Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 987.40 2,379.60
180 Zydus Lifesciences Limited Zydus Healthcare S.A. (Pty) Ltd Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 14,521.50 14,389.60
181 Zydus Lifesciences Limited Zydus Pharmaceuticals Mexico SA De CV Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 17,736.50 17,686.00
182 Zydus Lifesciences Limited Zydus Nikkho Farmaceutica Ltda. Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 11,716.60 9,140.10
183 Zydus Lifesciences Limited Zydus France, SAS Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 17,612.90 18,991.80
184 Zydus Lifesciences Limited Etna Biotech S.R.L. Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 1,070.50 1,069.10
185 Zydus Lifesciences Limited Zydus Pharmaceuticals UK Ltd. Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 288.80 495.30
186 Zydus Lifesciences Limited Laboratorios Combix S.L. Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 4,313.10 3,290.90
187 Zydus Lifesciences Limited Laboratorios Combix S.L. Subsidiary Company Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 515.80 0.00
188 Zydus Lifesciences Limited Zydus Worldwide DMCC Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 656.50 2,392.20
189 Zydus Lifesciences Limited Zydus Takeda Healthcare Private Limited Joint Ventures Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 804.90 804.90
190 Zydus Lifesciences Limited Zydus Hospitals and Healthcare Research Private Limited Enterprises significantly influenced by Directors and/ or their relatives Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 87.50 148.80
191 Zydus Healthcare Limited Zydus Hospitals and Healthcare Research Private Limited Enterprises significantly influenced by Directors and/ or their relatives Purchase of goods or services 1.00 Amount as approved by the Audit Committee. 1.00 0.00 0.00
192 Zydus Healthcare Limited Oneiro Chemicals Private Limited Enterprises significantly influenced by Directors and/ or their relatives Purchase of goods or services 3.40 Amount as approved by the Audit Committee. 3.40 0.00 0.00
193 Zydus Healthcare Limited Zydus Nikkho Farmaceutica Ltda. Subsidiary Company Purchase of goods or services 0.00 Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. 1.90 0.00 0.00
194 Zydus Healthcare Limited Cadmach Machinery Company Private Limited Enterprises significantly influenced by Directors and/ or their relatives Purchase of goods or services 3.20 Amount as approved by the Audit Committee. 3.20 0.00 0.00
195 Zydus Healthcare Limited Cadmach Machinery Company Private Limited Enterprises significantly influenced by Directors and/ or their relatives Purchase of fixed assets 53.10 Amount as approved by the Audit Committee. 53.10 0.00 0.00
196 Zydus Healthcare Limited Cadmach Machinery Company Private Limited Enterprises significantly influenced by Directors and/ or their relatives Purchase of goods or services 0.10 Amount as approved by the Audit Committee. 0.10 0.00 0.00
197 Zydus Healthcare Limited Mukesh M. Patel & Co., Proprietorship Firm Enterprises significantly influenced by Directors and/ or their relatives Purchase of goods or services 17.00 Amount as approved by the Audit Committee. 17.00 0.00 0.00
198 Zydus Healthcare Limited German Remedies Pharma Private Limited Subsidiary Company Sale of goods or services 0.00 Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. 739.30 0.00 0.00
199 Zydus Healthcare Limited Apollo Healthco Limited Enterprises significantly influenced by Directors and/ or their relatives Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 0.00 510.30
200 Zydus Healthcare Limited Apollo Healthco Limited Enterprises significantly influenced by Directors and/ or their relatives Purchase of goods or services 587.70 Amount as approved by the Audit Committee. 587.70 0.00 0.00
201 Zydus Healthcare Limited Zydus Hospitals and Healthcare Research Private Limited Enterprises significantly influenced by Directors and/ or their relatives Sale of goods or services 247.40 Amount as approved by the Audit Committee. 247.40 0.00 0.00
202 Zydus Healthcare Limited Ramanbhai Foundation Enterprises significantly influenced by Directors and/ or their relatives Sale of goods or services 8.20 Amount as approved by the Audit Committee. 8.20 0.00 0.00
203 Zydus Healthcare Limited Zydus Wellness Products Limited Subsidiary Company Sale of goods or services 148.00 Amount as approved by the Audit Committee. 148.00 0.00 0.00
204 Zydus Healthcare Limited Dr. Sharvil P. Patel Key Managerial Personnel Any other transaction Director Sitting Fees 0.00 N.A. 3.00 0.00 0.00
205 Zydus Healthcare Limited Zydus Pharmaceuticals Limited Subsidiary Company Purchase of goods or services 0.00 Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. 26.70 0.00 0.00
206 Zydus Healthcare Limited Sterling Biotech Limited Joint Ventures Purchase of goods or services 15.40 Amount as approved by the Audit Committee. 15.40 0.00 0.00
207 Zydus Healthcare Limited Sterling Biotech Limited Joint Ventures Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 16.30 16.20
208 Zydus Healthcare Limited Zydus Animal Health and Investments Limited Subsidiary Company Purchase of goods or services 0.00 Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. 30.10 0.00 0.00
209 Zydus Healthcare Limited Zydus Animal Health and Investments Limited Subsidiary Company Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 5.80 0.00
210 Zydus Healthcare Limited Zydus Foundation Enterprises significantly influenced by Directors and/ or their relatives Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 1.30 1.30
211 Zydus Healthcare Limited Zydus Lifesciences Limited Parent Company Loan 0.00 Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. 9,500.00 0.00 0.00 Loan 0.9500 5 Year Unsecured Business Purpose Textual Information(5)
212 Zydus Healthcare Limited Zydus Pharmaceuticals Limited Subsidiary Company Sale of goods or services 0.00 Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. 5.10 0.00 0.00
213 Zydus Healthcare Limited Recon Pharmaceuticals and Investments Subsidiary Company Any other transaction Share of profit Received 0.00 N.A. (0.50) 0.00 0.00
214 Zydus Healthcare Limited Zydus Healthcare Limited Employees Group Gratuity Scheme Post Employment Benefit Plans Any other transaction Contributions during the year [includes Employee's share and contribution] 62.50 Amount as approved by the Audit Committee. 62.50 0.00 0.00
215 Zydus Healthcare Limited Cadmach Machinery Company Private Limited Enterprises significantly influenced by Directors and/ or their relatives Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 0.80 61.10
216 Zydus Healthcare Limited Zydus Nikkho Farmaceutica Ltda. Subsidiary Company Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 9.20 11.10
217 Zydus Healthcare Limited Oneiro Chemicals Private Limited Enterprises significantly influenced by Directors and/ or their relatives Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 7.50 0.00
218 Zydus Healthcare Limited Mr. Tushar D. Shroff Key Managerial Personnel Any other transaction Director Sitting Fees 0.00 N.A. 3.00 0.00 0.00
219 Zydus Healthcare Limited Zydus Pharmaceuticals Limited Subsidiary Company Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 2.50 15.20
220 Zydus Healthcare Limited Zydus Medtech Private Limited Subsidiary Company Interest received 0.00 N.A. 206.20 0.00 0.00
221 Zydus Healthcare Limited Zydus Medtech Private Limited Subsidiary Company Loan 0.00 Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. 10,000.00 0.00 0.00 Loan 6.900 5 Year Unsecured Business Purpose Textual Information(6)
222 Zydus Healthcare Limited Zydus Medtech Private Limited Subsidiary Company Any other transaction Outstanding Receivables - Loans 0.00 N.A. 0.00 0.00 10,185.60
223 Zydus Healthcare Limited Zydus Medtech Private Limited Subsidiary Company Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 20.70 20.70
224 Zydus Healthcare Limited Ramanbhai Foundation Enterprises significantly influenced by Directors and/ or their relatives Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 2.80 2.00
225 Zydus Healthcare Limited Zydus Hospitals and Healthcare Research Private Limited Enterprises significantly influenced by Directors and/ or their relatives Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 67.90 48.60
226 Zydus Wellness Limited Zydus Wellness Products Limited Subsidiary Company Purchase of goods or services 0.00 Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. 622.70 0.00 0.00
227 Zydus Wellness Limited Zydus Wellness Products Limited Subsidiary Company Purchase of fixed assets 0.00 Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. 1.50 0.00 0.00
228 Zydus Wellness Limited Alidac UK Limited Subsidiary Company Loan 0.00 Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. 2,499.60 0.00 0.00
229 Zydus Wellness Limited Alidac UK Limited Subsidiary Company Interest received 0.00 N.A. 5.70 0.00 0.00
230 Zydus Wellness Limited Alidac UK Limited Subsidiary Company Investment 0.00 Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. 0.00 0.10 0.00
231 Zydus Wellness Limited Alidac UK Limited Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 381.80 413.70
232 Zydus Wellness Limited Alidac UK Limited Subsidiary Company Any other transaction Outstanding Receivables - Loans 0.00 N.A. 0.00 2,512.60 0.00
233 Zydus Wellness Limited Alidac UK Limited Subsidiary Company Sale of goods or services 0.00 Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. 834.50 0.00 0.00
234 Zydus Wellness Limited Mukesh M. Patel & Co., Proprietorship Firm Enterprises significantly influenced by Directors and/ or their relatives Purchase of goods or services 8.50 Amount as approved by the Audit Committee. 8.50 0.00 0.00
235 Zydus Wellness Limited Zydus Healthcare Limited Subsidiary Company Purchase of goods or services 16.80 Amount as approved by the Audit Committee. 16.80 0.00 0.00
236 Zydus Wellness Limited Zydus Healthcare Limited Subsidiary Company Sale of fixed assets 0.60 Amount as approved by the Audit Committee. 0.60 0.00 0.00
237 Zydus Wellness Limited Zydus Wellness Products Limited Subsidiary Company Sale of goods or services 0.00 Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. 28,371.60 0.00 0.00
238 Zydus Wellness Limited Zydus Wellness International DMCC Subsidiary Company Sale of goods or services 0.00 Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. 377.40 0.00 0.00
239 Zydus Wellness Limited Zydus Wellness Products Limited Subsidiary Company Sale of fixed assets 0.00 Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. 28.20 0.00 0.00
240 Zydus Wellness Limited Zydus Wellness Products Limited Subsidiary Company Sale of goods or services 0.00 Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. 2,414.40 0.00 0.00
241 Zydus Wellness Limited Zydus Wellness Products Limited Subsidiary Company Interest paid 0.00 N.A. 500.20 0.00 0.00
242 Zydus Wellness Limited Zydus Wellness Products Limited Subsidiary Company Loan 0.00 Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. 4,200.00 0.00 0.00
243 Zydus Wellness Limited Zydus Wellness International DMCC Subsidiary Company Any other transaction Reimbursement of Expenses Recovered 0.00 Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. 25.60 0.00 0.00
244 Zydus Wellness Limited Dr. Sharvil P. Patel Key Managerial Personnel Any other transaction Director Sitting Fees 0.00 N.A. 4.00 0.00 0.00
245 Zydus Lifesciences Limited Mr. Ganesh N. Nayak Key Managerial Personnel Remuneration 186.40 Amount as approved by the Audit Committee. 186.40 0.00 0.00
246 Zydus Wellness Limited Mr. Tarun Arora Key Managerial Personnel Remuneration 85.40 Amount as approved by the Audit Committee. 85.40 0.00 0.00
247 Zydus Wellness Limited Mr. Umesh V. Parikh Key Managerial Personnel Remuneration 121.90 Amount as approved by the Audit Committee. 121.90 0.00 0.00
248 Zydus Wellness Limited Mr. Nandish P. Joshi Key Managerial Personnel Remuneration 11.70 Amount as approved by the Audit Committee. 11.70 0.00 0.00
249 Zydus Wellness Limited Zydus Wellness International DMCC Subsidiary Company Interest received 0.00 N.A. 123.50 0.00 0.00
250 Zydus Pharmaceuticals Limited Zydus Infrastructure Private Limited Enterprises significantly influenced by Directors and/ or their relatives Purchase of fixed assets 42.40 Amount as approved by the Audit Committee. 42.40 0.00 0.00
251 Zydus Wellness Limited Apollo Healthco Limited Enterprises significantly influenced by Directors and/ or their relatives Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 0.30 0.00
252 Zydus Wellness Products Limited Apollo Healthco Limited Enterprises significantly influenced by Directors and/ or their relatives Sale of goods or services 2,360.80 Amount as approved by the Audit Committee. 2,360.80 0.00 0.00
253 Zydus Wellness Products Limited Apollo Healthco Limited Enterprises significantly influenced by Directors and/ or their relatives Any other transaction Reimbursement of Expenses paid 0.00 N.A. 580.00 0.00 0.00
254 Zydus Wellness Products Limited Apollo Healthco Limited Enterprises significantly influenced by Directors and/ or their relatives Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 560.90 654.60
255 Zydus Wellness Products Limited Indifoss Analytical Private Limited Enterprises significantly influenced by Directors and/ or their relatives Purchase of goods or services 8.50 Amount as approved by the Audit Committee. 8.50 0.00 0.00
256 Zydus Wellness Products Limited Indifoss Analytical Private Limited Enterprises significantly influenced by Directors and/ or their relatives Purchase of fixed assets 0.90 Amount as approved by the Audit Committee. 0.90 0.00 0.00
257 Zydus Wellness Products Limited Indifoss Analytical Private Limited Enterprises significantly influenced by Directors and/ or their relatives Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 0.40 0.00
258 Zydus Wellness Limited Zydus Wellness International DMCC Subsidiary Company Any other transaction Outstanding Receivables - Loans 0.00 N.A. 0.00 3,792.00 3,832.00
259 Zydus Wellness Limited Zydus Wellness Products Limited Subsidiary Company Any other transaction Outstanding Payables - Loans 0.00 N.A. 0.00 12,900.00 17,550.20
260 Zydus Wellness Limited Zydus Wellness Products Limited Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 1,566.90 5,581.40
261 Zydus Wellness Limited Zydus Wellness International DMCC Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 408.80 728.50
262 Zydus Wellness Products Limited Zydus Healthcare Limited Subsidiary Company Purchase of goods or services 765.00 Amount as approved by the Audit Committee. 765.00 0.00 0.00
263 Zydus Wellness Products Limited Mukesh M. Patel & Co., Proprietorship Firm Enterprises significantly influenced by Directors and/ or their relatives Purchase of goods or services 11.00 Amount as approved by the Audit Committee. 11.00 0.00 0.00
264 Zydus Wellness Products Limited Mr. Tarun Arora Key Managerial Personnel Remuneration 392.90 Amount as approved by the Audit Committee. 392.90 0.00 0.00
265 Zydus Wellness Products Limited Zydus Wellness International DMCC Subsidiary Company Sale of goods or services 0.00 Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. 1,639.10 0.00 0.00
266 Zydus Wellness Products Limited Zydus Healthcare Limited Subsidiary Company Sale of goods or services 114.30 Amount as approved by the Audit Committee. 114.30 0.00 0.00
267 Zydus Wellness Products Limited Zydus Wellness International DMCC Subsidiary Company Sale of goods or services 0.00 Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. 23.50 0.00 0.00
268 Zydus Wellness Products Limited Zydus Healthcare Limited Subsidiary Company Sale of fixed assets 1.10 Amount as approved by the Audit Committee. 1.10 0.00 0.00
269 Zydus Wellness Products Limited Zydus Wellness International DMCC Subsidiary Company Any other transaction Reimbursement of Expenses Recovered 0.00 N.A. 97.90 0.00 0.00
270 Zydus Wellness Products Limited Zydus Healthcare Limited Subsidiary Company Sale of goods or services 82.50 Amount as approved by the Audit Committee. 82.50 0.00 0.00
271 Zydus Wellness Products Limited Zydus Wellness BD Private Limited Subsidiary Company Investment 0.00 Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. 0.00 377.10 0.00
272 Zydus Wellness Products Limited LM Manufacturing India Private Limited Subsidiary Company Sale of goods or services 21.00 Amount as approved by the Audit Committee. 21.00 0.00 0.00
273 Zydus Wellness Products Limited LM Manufacturing India Private Limited Subsidiary Company Any other transaction Reimbursement of Expenses Recovered 0.00 N.A. 3.90 0.00 0.00
274 Zydus Wellness Products Limited LM Manufacturing India Private Limited Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 0.70 0.70
275 Zydus Wellness Products Limited Heinz India Private Limited Pension Fund Post Employment Benefit Plans Any other transaction Contributions during the year [includes Employee's share and contribution] 23.90 Amount as approved by the Audit Committee. 23.90 0.00 0.00
276 Zydus Wellness Products Limited Zydus Wellness Sikkim Employees Group Gratuity Scheme Post Employment Benefit Plans Any other transaction Contributions during the year [includes Employee's share and contribution] 8.00 Amount as approved by the Audit Committee. 8.00 0.00 0.00
277 Zydus Wellness Products Limited Zydus Healthcare Limited Subsidiary Company Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 0.00 178.40
278 Zydus Wellness Products Limited Comfort Click Limited (UK) Subsidiary Company Sale of goods or services 0.00 Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. 413.50 0.00 0.00
279 Zydus Wellness Products Limited Comfort Click Limited (UK) Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 0.00 413.50
280 Zydus Wellness Products Limited Cadmach Machinery Company Private Limited Enterprises significantly influenced by Directors and/ or their relatives Purchase of goods or services 3.80 Amount as approved by the Audit Committee. 3.80 0.00 0.00
281 Zydus Wellness Products Limited Zydus Medtech Private Limited Subsidiary Company Sale of goods or services 24.60 Amount as approved by the Audit Committee. 24.60 0.00 0.00
282 Zydus Wellness Products Limited Zydus Medtech Private Limited Subsidiary Company Any other transaction Reimbursement of Expenses Recovered 0.00 N.A. 2.90 0.00 0.00
283 Zydus Wellness Products Limited Zydus Medtech Private Limited Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 3.90 19.70
284 Zydus Wellness Products Limited Zydus Wellness International DMCC Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 2,671.80 4,015.50
285 Zydus Wellness Products Limited Zydus Healthcare Limited Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 88.10 0.00
286 German Remedies Pharma Private Limited German Remedies Pharmaceuticals Private Limited Emp Group Gratuity Scheme Post Employment Benefit Plans Any other transaction Contributions during the year [includes Employee's share and contribution] 3.00 Amount as approved by the Audit Committee. 3.00 0.00 0.00
287 German Remedies Pharma Private Limited Zydus Healthcare Limited Subsidiary Company Sale of goods or services 0.00 Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. 1,976.60 0.00 0.00
288 German Remedies Pharma Private Limited Zydus Foundation Enterprises significantly influenced by Directors and/ or their relatives Sale of goods or services 31.90 Amount as approved by the Audit Committee. 31.90 0.00 0.00
289 German Remedies Pharma Private Limited Zydus Foundation Enterprises significantly influenced by Directors and/ or their relatives Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 0.00 2.90
290 German Remedies Pharma Private Limited Recon Pharmaceuticals and Investments Subsidiary Company Any other transaction Share of profit Received 0.00 N.A. (0.10) 0.00 0.00
291 German Remedies Pharma Private Limited Zydus Healthcare Limited Subsidiary Company Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 0.00 67.70
292 German Remedies Pharma Private Limited Zydus Healthcare Limited Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 83.30 45.10
293 Zydus Pharmaceuticals Limited Zydus Infrastructure Private Limited Enterprises significantly influenced by Directors and/ or their relatives Purchase of goods or services 263.90 Amount as approved by the Audit Committee. 263.90 0.00 0.00
294 Zydus Pharmaceuticals Limited Zydus Animal Health and Investments Limited Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 2.50 2.50
295 Zydus Pharmaceuticals Limited Zydus Lifesciences Global FZE [UAE] Subsidiary Company Sale of goods or services 0.00 Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. 6,486.90 0.00 0.00
296 Zydus Pharmaceuticals Limited Zydus Infrastructure Private Limited Enterprises significantly influenced by Directors and/ or their relatives Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 91.00 0.00
297 Zydus Pharmaceuticals Limited Zydus Pharmaceuticals Limited Employees Group Gratuity Scheme Post Employment Benefit Plans Any other transaction Contributions during the year [includes Employee's share and contribution] 1.00 Amount as approved by the Audit Committee. 1.00 0.00 0.00
298 Zydus Pharmaceuticals Limited Zydus Lifesciences Global FZE [UAE] Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 1,007.00 7,493.90
299 Zydus Animal Health and Investments Limited Cadmach Machinery Company Private Limited Enterprises significantly influenced by Directors and/ or their relatives Purchase of goods or services 0.40 Amount as approved by the Audit Committee. 0.40 0.00 0.00
300 Zydus Animal Health and Investments Limited Dialforhealth Unity Limited Subsidiary Company Interest received 0.00 N.A. 0.10 0.00 0.00
301 Zydus Animal Health and Investments Limited Dialforhealth Unity Limited Subsidiary Company Any other transaction Outstanding Receivables - Loans 0.00 N.A. 0.00 2.10 2.20
302 Zydus Animal Health and Investments Limited Biochem Pharmaceutical Private Limited Subsidiary Company Investment 0.00 Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. 0.00 0.00 0.00
303 Zydus Animal Health and Investments Limited Zydus Medtech Private Limited Subsidiary Company Interest received 0.00 N.A. 1,279.50 0.00 0.00
304 Zydus Animal Health and Investments Limited Zydus Infrastructure Private Limited Enterprises significantly influenced by Directors and/ or their relatives Purchase of goods or services 35.00 Amount as approved by the Audit Committee. 35.00 0.00 0.00
305 Zydus Animal Health and Investments Limited ZyVet Animal Health Inc Subsidiary Company Sale of goods or services 0.00 Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. 10,200.80 0.00 0.00
306 Zydus Animal Health and Investments Limited Viona Pharmaceuticals INC Subsidiary Company Interest received 0.00 N.A. 102.00 0.00 0.00
307 Zydus Animal Health and Investments Limited ZyVet Animal Health Inc Subsidiary Company Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 2,375.10 0.00
308 Zydus Animal Health and Investments Limited Cadmach Machinery Company Private Limited Enterprises significantly influenced by Directors and/ or their relatives Purchase of goods or services 2.60 Amount as approved by the Audit Committee. 2.60 0.00 0.00
309 Zydus Animal Health and Investments Limited Cadmach Machinery Company Private Limited Enterprises significantly influenced by Directors and/ or their relatives Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 0.40 0.00
310 Zydus Animal Health and Investments Limited Zydus Infrastructure Private Limited Enterprises significantly influenced by Directors and/ or their relatives Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 11.50 15.20
311 Zydus Animal Health and Investments Limited Viona Pharmaceuticals INC Subsidiary Company Any other transaction Outstanding Receivables - Loans 0.00 N.A. 0.00 4,740.00 4,790.00
312 Zydus Animal Health and Investments Limited Zydus Medtech Private Limited Subsidiary Company Any other transaction Outstanding Receivables - Loans 0.00 N.A. 0.00 40,389.90 41,151.50
313 Zydus Animal Health and Investments Limited ZyVet Animal Health Inc Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 4,868.60 9,398.90
314 Dialforhealth Unity Limited Dialforhealth Greencross Limited Subsidiary Company Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 0.10 0.10
315 Zydus Pharmaceuticals (USA) Inc. NAI Laboratories Limited Enterprises significantly influenced by Directors and/ or their relatives Purchase of goods or services 535.90 Amount as approved by the Audit Committee. 535.90 0.00 0.00
316 Zydus Pharmaceuticals (USA) Inc. Navinta III, Inc Enterprises significantly influenced by Directors and/ or their relatives Purchase of goods or services 557.90 Amount as approved by the Audit Committee. 557.90 0.00 0.00
317 Zydus Pharmaceuticals (USA) Inc. Navinta LLC Enterprises significantly influenced by Directors and/ or their relatives Purchase of goods or services 5,297.50 Amount as approved by the Audit Committee. 5,297.50 0.00 0.00
318 Zydus Pharmaceuticals (USA) Inc. Navinta NV, Inc. Enterprises significantly influenced by Directors and/ or their relatives Purchase of goods or services 2,775.00 Amount as approved by the Audit Committee. 2,775.00 0.00 0.00
319 Zydus Pharmaceuticals (USA) Inc. Assertio Holdings Inc. [USA] Subsidiary Company Any other transaction Reimbursement of Expenses Recovered 0.00 N.A. 5,580.80 0.00 0.00
320 Zydus Pharmaceuticals (USA) Inc. Assertio Holdings Inc. [USA] Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 0.00 30.80
321 Zydus Pharmaceuticals (USA) Inc. Zydus Healthcare (USA) LLC Subsidiary Company Loan 0.00 Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. 285.50 0.00 0.00
322 Zydus Pharmaceuticals (USA) Inc. Sentynl Therapeutics Inc. Subsidiary Company Sale of goods or services 0.00 Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. 61.70 0.00 0.00
323 Zydus Pharmaceuticals (USA) Inc. Viona Pharmaceuticals INC Subsidiary Company Sale of goods or services 0.00 Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. 125.20 0.00 0.00
324 Zydus Pharmaceuticals (USA) Inc. ZyVet Animal Health Inc Subsidiary Company Sale of goods or services 0.00 Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. 153.60 0.00 0.00
325 Zydus Pharmaceuticals (USA) Inc. Zydus Lifesciences Global FZE [UAE] Subsidiary Company Purchase of goods or services 0.00 Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. 33,845.60 0.00 0.00
326 Zydus Pharmaceuticals (USA) Inc. Zydus Lifesciences Global FZE [UAE] Subsidiary Company Any other transaction Reimbursement of Expenses Recovered 0.00 N.A. 4,270.30 0.00 0.00
327 Zydus Pharmaceuticals (USA) Inc. Zydus Lifesciences Global FZE [UAE] Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 1,561.20 4,880.60
328 Zydus Pharmaceuticals (USA) Inc. Zydus Lifesciences Global FZE [UAE] Subsidiary Company Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 6,289.10 6,708.40
329 Zydus Pharmaceuticals (USA) Inc. Zydus Healthcare (USA) LLC Subsidiary Company Any other transaction Reimbursement of Expenses Recovered 0.00 N.A. 2.60 0.00 0.00
330 Zydus Pharmaceuticals (USA) Inc. Zydus Therapeutics INC Subsidiary Company Sale of goods or services 0.00 Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. 105.90 0.00 0.00
331 Zydus Pharmaceuticals (USA) Inc. Navinta LLC Enterprises significantly influenced by Directors and/ or their relatives Any other transaction Reimbursement of Expenses paid 0.00 N.A. 120.90 0.00 0.00
332 Zydus Pharmaceuticals (USA) Inc. Navinta LLC Enterprises significantly influenced by Directors and/ or their relatives Any other transaction Reimbursement of Expenses Recovered 0.00 N.A. 5.70 0.00 0.00
333 Zydus Pharmaceuticals (USA) Inc. Sentynl Therapeutics Inc. Subsidiary Company Any other transaction Reimbursement of Expenses Recovered 0.00 N.A. 9.30 0.00 0.00
334 Zydus Pharmaceuticals (USA) Inc. Viona Pharmaceuticals INC Subsidiary Company Any other transaction Reimbursement of Expenses Recovered 0.00 N.A. 12.30 0.00 0.00
335 Zydus Pharmaceuticals (USA) Inc. ZyVet Animal Health Inc Subsidiary Company Any other transaction Reimbursement of Expenses Recovered 0.00 N.A. 1.70 0.00 0.00
336 Zydus Pharmaceuticals (USA) Inc. Zydus Therapeutics INC Subsidiary Company Any other transaction Reimbursement of Expenses paid 0.00 N.A. 9.10 0.00 0.00
337 Zydus Pharmaceuticals (USA) Inc. Zydus Therapeutics INC Subsidiary Company Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 0.00 9.20
338 Zydus Pharmaceuticals (USA) Inc. Zydus Therapeutics INC Subsidiary Company Any other transaction Reimbursement of Expenses Recovered 0.00 N.A. 97.10 0.00 0.00
339 Zydus Pharmaceuticals (USA) Inc. Zynext Ventures USA LLC Subsidiary Company Any other transaction Reimbursement of Expenses Recovered 0.00 N.A. 0.10 0.00 0.00
340 Zydus Pharmaceuticals (USA) Inc. Zydus Healthcare (USA) LLC Subsidiary Company Loan 0.00 Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. 475.80 0.00 0.00 Loan 0.500 1 Year Unsecured Business Purpose Textual Information(7)
341 Zydus Pharmaceuticals (USA) Inc. Zydus Healthcare (USA) LLC Subsidiary Company Interest received 0.00 N.A. 8.00 0.00 0.00
342 Zydus Pharmaceuticals (USA) Inc. Sentynl Therapeutics Inc. Subsidiary Company Any other transaction Reimbursement of Expenses paid 0.00 N.A. 7.10 0.00 0.00
343 Zydus Pharmaceuticals (USA) Inc. Sentynl Therapeutics Inc. Subsidiary Company Interest received 0.00 N.A. 620.30 0.00 0.00
344 Zydus Pharmaceuticals (USA) Inc. Viona Pharmaceuticals INC Subsidiary Company Interest received 0.00 N.A. 420.00 0.00 0.00
345 Zydus Pharmaceuticals (USA) Inc. ZyVet Animal Health Inc Subsidiary Company Interest received 0.00 N.A. 71.90 0.00 0.00
346 Zydus Pharmaceuticals (USA) Inc. Zydus Therapeutics INC Subsidiary Company Interest received 0.00 N.A. 3,205.60 0.00 0.00
347 Zydus Pharmaceuticals (USA) Inc. Zydus Pharmaceuticals Canada Inc. Subsidiary Company Any other transaction Reimbursement of Expenses Recovered 0.00 N.A. 0.80 0.00 0.00
348 Zydus Pharmaceuticals (USA) Inc. Zydus Pharmaceuticals Canada Inc. Subsidiary Company Sale of goods or services 0.00 Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. 63.90 0.00 0.00
349 Zydus Pharmaceuticals (USA) Inc. Zydus Pharmaceuticals Canada Inc. Subsidiary Company Interest received 0.00 N.A. 28.10 0.00 0.00
350 Zydus Pharmaceuticals (USA) Inc. Zydus Pharmaceuticals Canada Inc. Subsidiary Company Any other transaction Outstanding Receivables - Loans 0.00 N.A. 0.00 1,328.20 1,341.90
351 Zydus Pharmaceuticals (USA) Inc. Zydus Pharmaceuticals Canada Inc. Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 36.30 42.10
352 Zydus Pharmaceuticals (USA) Inc. ZyVet Animal Health Inc Subsidiary Company Interest paid 0.00 N.A. 3.20 0.00 0.00
353 Zydus Pharmaceuticals (USA) Inc. ZyVet Animal Health Inc Subsidiary Company Any other transaction Outstanding Payables - Loans 0.00 N.A. 0.00 0.00 1,963.80
354 Zydus Pharmaceuticals (USA) Inc. ZyVet Animal Health Inc Subsidiary Company Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 0.00 3.20
355 Zydus Pharmaceuticals (USA) Inc. Zydus Therapeutics INC Subsidiary Company Loan 0.00 Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. 38,549.80 0.00 0.00 Loan 0.500 1 Year Unsecured Business Purpose Textual Information(8)
356 Zydus Pharmaceuticals (USA) Inc. Sentynl Therapeutics Inc. Subsidiary Company Loan 0.00 Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. 15,701.40 0.00 0.00
357 Zydus Pharmaceuticals (USA) Inc. ZyVet Animal Health Inc Subsidiary Company Loan 0.00 Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. 5,376.50 0.00 0.00
358 Zydus Pharmaceuticals (USA) Inc. Zynext Ventures USA LLC Subsidiary Company Loan 0.00 Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. 27,881.90 0.00 0.00 Loan 0.500 1 Year Unsecured Business Purpose Textual Information(9)
359 Zydus Pharmaceuticals (USA) Inc. Zynext Ventures USA LLC Subsidiary Company Loan 0.00 Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. 27,881.90 0.00 0.00
360 Zydus Pharmaceuticals (USA) Inc. Zynext Ventures USA LLC Subsidiary Company Interest received 0.00 N.A. 71.20 0.00 0.00
361 Zydus Pharmaceuticals (USA) Inc. NAI Laboratories Limited Enterprises significantly influenced by Directors and/ or their relatives Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 232.00 0.00
362 Zydus Pharmaceuticals (USA) Inc. Navinta III, Inc Enterprises significantly influenced by Directors and/ or their relatives Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 1,826.00 63.40
363 Zydus Pharmaceuticals (USA) Inc. Navinta LLC Enterprises significantly influenced by Directors and/ or their relatives Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 55.40 1,005.80
364 Zydus Pharmaceuticals (USA) Inc. Navinta NV, Inc. Enterprises significantly influenced by Directors and/ or their relatives Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 141.40 169.20
365 Zydus Pharmaceuticals (USA) Inc. Zydus Healthcare (USA) LLC Subsidiary Company Any other transaction Outstanding Receivables - Loans 0.00 N.A. 0.00 474.40 671.00
366 Zydus Pharmaceuticals (USA) Inc. Sentynl Therapeutics Inc. Subsidiary Company Any other transaction Outstanding Receivables - Loans 0.00 N.A. 0.00 33,077.60 17,253.00
367 Zydus Pharmaceuticals (USA) Inc. Viona Pharmaceuticals INC Subsidiary Company Loan 0.00 Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. 8,039.20 0.00 0.00
368 Zydus Pharmaceuticals (USA) Inc. Viona Pharmaceuticals INC Subsidiary Company Any other transaction Outstanding Receivables - Loans 0.00 N.A. 0.00 21,797.30 13,925.10
369 Zydus Pharmaceuticals (USA) Inc. ZyVet Animal Health Inc Subsidiary Company Any other transaction Outstanding Receivables - Loans 0.00 N.A. 0.00 5,360.20 0.00
370 Zydus Pharmaceuticals (USA) Inc. Zydus Therapeutics INC Subsidiary Company Any other transaction Outstanding Receivables - Loans 0.00 N.A. 0.00 1,34,141.00 1,74,356.00
371 Zydus Pharmaceuticals (USA) Inc. Sentynl Therapeutics Inc. Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 38.70 316.10
372 Zydus Pharmaceuticals (USA) Inc. Viona Pharmaceuticals INC Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 187.40 122.50
373 Zydus Pharmaceuticals (USA) Inc. ZyVet Animal Health Inc Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 115.50 77.90
374 Zydus Pharmaceuticals (USA) Inc. Zylidac Bio LLC, USA Subsidiary Company Loan 0.00 Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. 36,428.40 0.00 0.00 Loan 0.500 1 Year Unsecured Business Purpose Textual Information(10)
375 Zydus Pharmaceuticals (USA) Inc. Zylidac Bio LLC, USA Subsidiary Company Any other transaction Reimbursement of Expenses Recovered 0.00 N.A. 322.70 0.00 0.00
376 Zydus Pharmaceuticals (USA) Inc. Zylidac Bio LLC, USA Subsidiary Company Interest received 0.00 N.A. 2,222.70 0.00 0.00
377 Zydus Pharmaceuticals (USA) Inc. Zylidac Bio LLC, USA Subsidiary Company Any other transaction Outstanding Receivables - Loans 0.00 N.A. 0.00 84,783.30 1,21,664.70
378 Zydus Pharmaceuticals (USA) Inc. Zynext Ventures USA LLC Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 2.10 0.00
379 Zydus Pharmaceuticals (USA) Inc. Zydus Therapeutics INC Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 559.20 730.10
380 Zydus Worldwide DMCC Zydus Pharmaceuticals (USA) Inc. Subsidiary Company Any other transaction Reimbursement of Expenses paid 0.00 N.A. 1,904.20 0.00 0.00
381 Zydus Worldwide DMCC Zydus Pharmaceuticals (USA) Inc. Subsidiary Company Sale of goods or services 0.00 Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. 4,164.30 0.00 0.00
382 Zydus Worldwide DMCC Zydus Netherlands B.V. Subsidiary Company Interest received 0.00 N.A. 221.40 0.00 0.00
383 Zydus Worldwide DMCC Zydus Netherlands B.V. Subsidiary Company Investment 0.00 Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. 0.00 13,354.00 0.00
384 Zydus Worldwide DMCC Zydus France, SAS Subsidiary Company Investment 0.00 Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. 0.00 4,365.00 0.00
385 Zydus Worldwide DMCC Zydus Netherlands B.V. Subsidiary Company Any other transaction Outstanding Receivables - Loans 0.00 N.A. 0.00 11,380.90 11,721.50
386 Zydus Worldwide DMCC Zydus Pharmaceuticals (USA) Inc. Subsidiary Company Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 7.80 1,917.30
387 Zydus Worldwide DMCC Zydus Pharmaceuticals (USA) Inc. Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 7,431.30 11,673.70
388 Zydus Therapeutics INC Zylidac Bio LLC, USA Subsidiary Company Any other transaction Reimbursement of Expenses Recovered 0.00 N.A. 14.70 0.00 0.00
389 Zydus Healthcare (USA) LLC Zydus Pharmaceuticals (USA) Inc. Subsidiary Company Purchase of goods or services 0.00 Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. 29.60 0.00 0.00
390 Zydus Healthcare (USA) LLC Zydus Pharmaceuticals (USA) Inc. Subsidiary Company Sale of goods or services 0.00 Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. 219.70 0.00 0.00
391 Zydus Healthcare (USA) LLC Zydus Therapeutics INC Subsidiary Company Sale of goods or services 0.00 Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. 36.30 0.00 0.00
392 Zydus Healthcare (USA) LLC Zydus Pharmaceuticals (USA) Inc. Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 0.00 0.10
393 Zydus Healthcare (USA) LLC Zydus Pharmaceuticals (USA) Inc. Subsidiary Company Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 17.30 17.10
394 ZyVet Animal Health Inc Zydus Animal Health and Investments Limited Subsidiary Company Any other transaction Reimbursement of Expenses Recovered 0.00 N.A. 167.60 0.00 0.00
395 ZyVet Animal Health Inc Zydus Pharmaceuticals (USA) Inc. Subsidiary Company Loan 0.00 Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. 1,949.70 0.00 0.00 Loan 0.500 1 Year Unsecured Business Purpose Textual Information(11)
396 Zydus Wellness International DMCC Zydus Wellness General Trading DWC LLC Subsidiary Company Any other transaction Reimbursement of Expenses Recovered 0.00 N.A. 37.30 0.00 0.00
397 Zydus Wellness International DMCC Zydus Wellness General Trading DWC LLC Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 0.00 37.30
398 Zydus Wellness International DMCC Zydus Wellness Trading LLC Subsidiary Company Any other transaction Reimbursement of Expenses Recovered 0.00 N.A. 26.60 0.00 0.00
399 Zydus Wellness International DMCC Zydus Wellness Trading LLC Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 0.00 26.60
400 Zydus Wellness International DMCC Zydus Worldwide DMCC Subsidiary Company Purchase of goods or services 0.00 Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. 5.70 0.00 0.00
401 Zydus Wellness International DMCC Zydus Worldwide DMCC Subsidiary Company Any other transaction Reimbursement of Expenses Recovered 0.00 N.A. 6.00 0.00 0.00
402 Zydus Wellness International DMCC Zydus Worldwide DMCC Subsidiary Company Any other transaction Reimbursement of Expenses paid 0.00 N.A. 1.90 0.00 0.00
403 Zydus Wellness International DMCC Zydus Worldwide DMCC Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 12.20 10.70
404 Zydus International Private Limited RIC Chemicals LTD Enterprises significantly influenced by Directors and/ or their relatives Purchase of goods or services 18.60 Amount as approved by the Audit Committee. 18.60 0.00 0.00
405 Zydus International Private Limited Zydus Netherlands B.V. Subsidiary Company Interest received 0.00 N.A. 58.40 0.00 0.00
406 Zydus International Private Limited Zydus Healthcare S.A. (Pty) Ltd Subsidiary Company Interest received 0.00 N.A. 52.40 0.00 0.00
407 Zydus International Private Limited Zydus France, SAS Subsidiary Company Interest received 0.00 N.A. 46.10 0.00 0.00
408 Zydus International Private Limited Laboratorios Combix S.L. Subsidiary Company Interest received 0.00 N.A. 55.30 0.00 0.00
409 Zydus International Private Limited Zydus Lifesciences Global FZE [UAE] Subsidiary Company Loan 0.00 Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. 1,219.20 0.00 0.00 Loan 0.8500 5 Year Unsecured Business Purpose Textual Information(12)
410 Zydus International Private Limited Zydus Lifesciences Global FZE [UAE] Subsidiary Company Interest received 0.00 N.A. 4,319.00 0.00 0.00
411 Zydus International Private Limited Zydus Lifesciences Global FZE [UAE] Subsidiary Company Any other transaction Outstanding Receivables - Loans 0.00 N.A. 0.00 1,86,215.30 1,90,769.80
412 Zydus International Private Limited Zydus Netherlands B.V. Subsidiary Company Any other transaction Outstanding Receivables - Loans 0.00 N.A. 0.00 3,118.50 3,171.00
413 Zydus International Private Limited Zydus Healthcare S.A. (Pty) Ltd Subsidiary Company Any other transaction Outstanding Receivables - Loans 0.00 N.A. 0.00 4,416.50 4,461.00
414 Zydus International Private Limited Zydus France, SAS Subsidiary Company Any other transaction Outstanding Receivables - Loans 0.00 N.A. 0.00 3,016.90 3,057.40
415 Zydus International Private Limited Laboratorios Combix S.L. Subsidiary Company Any other transaction Outstanding Receivables - Loans 0.00 N.A. 0.00 4,069.20 4,117.10
416 Zydus Netherlands B.V. Zydus Nikkho Farmaceutica Ltda. Subsidiary Company Investment 0.00 Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. 0.00 13,301.90 0.00
417 Zydus France, SAS Laboratorios Combix S.L. Subsidiary Company Any other transaction Reimbursement of Expenses paid 0.00 N.A. 4.70 0.00 0.00
418 Zydus France, SAS Laboratorios Combix S.L. Subsidiary Company Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 0.00 5.20
419 Laboratorios Combix S.L. Zydus Pharmaceuticals UK Ltd. Subsidiary Company Any other transaction Reimbursement of Expenses paid 0.00 N.A. 3.20 0.00 0.00
420 Zydus Healthcare S.A. (Pty) Ltd DI Consultancy Enterprises significantly influenced by Directors and/ or their relatives Purchase of goods or services 154.90 Amount as approved by the Audit Committee. 154.90 0.00 0.00
421 Zydus Healthcare S.A. (Pty) Ltd Alidac Pharmaceuticals SA (Pty) Ltd Subsidiary Company Any other transaction Outstanding Receivables - Loans 0.00 N.A. 0.00 4,995.80 5,285.10
422 Zydus Healthcare S.A. (Pty) Ltd Alidac Pharmaceuticals SA (Pty) Ltd Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 606.90 641.90
423 Script Management Services (Pty) Ltd Zydus Healthcare S.A. (Pty) Ltd Subsidiary Company Sale of goods or services 0.00 Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. 4,920.50 0.00 0.00
424 Script Management Services (Pty) Ltd Zydus Healthcare S.A. (Pty) Ltd Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 245.40 1,424.10
425 Zydus Healthcare Philippines Inc. RJ Conception Law Office Enterprises significantly influenced by Directors and/ or their relatives Purchase of goods or services 0.90 Amount as approved by the Audit Committee. 0.90 0.00 0.00
426 Alidac Healthcare (Myanmar) Limited Cadmach Machinery Company Private Limited Enterprises significantly influenced by Directors and/ or their relatives Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 0.00 2.00
427 Zynext Ventures Pte. Ltd. Zynext Ventures USA LLC Subsidiary Company Investment 0.00 Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. 19,032.00 12,587.00 31,619.00 Investment 0 N.A Unsecured Business Purpose Textual Information(13)
428 Zydus Pharmaceuticals UK Ltd. LiqMeds Limited Subsidiary Company Interest received 0.00 N.A. 172.90 0.00 0.00
429 Zydus Pharmaceuticals UK Ltd. LM Manufacturing Limited Subsidiary Company Interest received 0.00 N.A. 0.90 0.00 0.00
430 Zydus Pharmaceuticals UK Ltd. LM Manufacturing Limited Subsidiary Company Loan 0.00 Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. 5,072.90 0.00 0.00
431 Zydus Pharmaceuticals UK Ltd. LM Manufacturing Limited Subsidiary Company Purchase of goods or services 0.00 Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. 305.30 0.00 0.00
432 Zydus Pharmaceuticals UK Ltd. LM Manufacturing Limited Subsidiary Company Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 38.80 364.60
433 Zydus Pharmaceuticals UK Ltd. LM Manufacturing Limited Subsidiary Company Any other transaction Outstanding Receivables - Loans 0.00 N.A. 0.00 5,054.60 0.00
434 Zydus Pharmaceuticals UK Ltd. LiqMeds Limited Subsidiary Company Loan 0.00 Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. 8,868.30 0.00 0.00
435 Zydus Pharmaceuticals UK Ltd. LiqMeds Limited Subsidiary Company Any other transaction Outstanding Receivables - Loans 0.00 N.A. 0.00 8,945.30 0.00
436 Zydus Lifesciences Global FZE [UAE] Zydus Lifesciences Limited Parent Company Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 54,920.60 58,774.70
437 Zydus Lifesciences Global FZE [UAE] Zydus Worldwide DMCC Subsidiary Company Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 475.10 495.30
438 Zydus Lifesciences Global FZE [UAE] Viona Pharmaceuticals INC Subsidiary Company Sale of goods or services 0.00 Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. 6,368.20 0.00 0.00
439 Zydus Lifesciences Global FZE [UAE] Zydus Healthcare (USA) LLC Subsidiary Company Purchase of goods or services 0.00 Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. 224.40 0.00 0.00
440 Zydus Lifesciences Global FZE [UAE] Zydus Healthcare (USA) LLC Subsidiary Company Any other transaction Reimbursement of Expenses paid 0.00 N.A. 263.20 0.00 0.00
441 Zydus Lifesciences Global FZE [UAE] Zydus Healthcare (USA) LLC Subsidiary Company Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 36.20 98.40
442 Zydus Lifesciences Global FZE [UAE] Viona Pharmaceuticals INC Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 2,792.90 3,669.40
443 LiqMeds Worldwide Limited LiqMeds Lifecare Limited Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 207.10 210.40
444 LiqMeds Worldwide Limited LiqMeds Limited Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 731.50 743.40
445 LM Manufacturing Limited LiqMeds Limited Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 0.00 1,069.30
446 LM Manufacturing India Private Limited LM Manufacturing Limited Subsidiary Company Sale of goods or services 0.00 Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. 382.70 0.00 0.00
447 LiqMeds Worldwide Limited LM Manufacturing Limited Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 40,019.50 56,724.30
448 LM Manufacturing Limited Medsolutions (Europe) Limited Subsidiary Company Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 18.60 18.90
449 LM Manufacturing Limited Oncosol Limited Joint Ventures Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 32.70 16.60
450 LiqMeds Limited LM Manufacturing Limited Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 7,281.70 0.00
451 LiqMeds Lifecare Limited LM Manufacturing Limited Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 1,264.50 1,285.10
452 LM Manufacturing India Private Limited LM Manufacturing Limited Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 78.40 59.20
453 LiqMeds Lifecare Limited LiqMeds Limited Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 11.20 11.40
454 LiqMeds Lifecare Limited Medsolutions (Europe) Limited Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 112.60 114.40
455 LiqMeds Lifecare Limited Oncosol Limited Joint Ventures Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 359.20 1,250.10
456 Medsolutions (Europe) Limited LiqMeds Worldwide Limited Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 144.60 146.90
457 Medsolutions (Europe) Limited Oncosol Limited Joint Ventures Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 5.40 5.50
458 Zydus Medtech Private Limited Zydus Medtech France SAS Subsidiary Company Investment 0.00 Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. 0.00 0.00 0.00
459 Zydus Medtech Private Limited Zydus Medtech Private Ltd. Employees Group Gratuity Scheme Post Employment Benefit Plans Any other transaction Contributions during the year [includes Employee's share and contribution] 52.00 Amount as approved by the Audit Committee. 52.00 0.00 0.00
460 Zydus Medtech Private Limited Zydus Hospitals and Healthcare Research Private Limited Enterprises significantly influenced by Directors and/ or their relatives Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 0.00 0.40
461 Zydus Medtech Private Limited Zydus Hospitals and Healthcare Research Private Limited Enterprises significantly influenced by Directors and/ or their relatives Purchase of goods or services 0.40 Amount as approved by the Audit Committee. 0.40 0.00 0.00
462 German Remedies Pharma Private Limited Zydus Animal Health and Investments Limited Subsidiary Company Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 0.00 0.50
463 Zydus Worldwide DMCC Zydus Lifesciences Global FZE [UAE] Subsidiary Company Any other transaction Reimbursement of Expenses Recovered 0.00 N.A. 15.20 0.00 0.00
464 Zydus Medtech France SAS Amplitude Surgical SAS Subsidiary Company Interest received 0.00 N.A. 1,514.10 0.00 0.00
465 Zydus Medtech France SAS Amplitude SAS [France] Subsidiary Company Loan 0.00 Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. 5,642.60 0.00 0.00
466 Zydus Medtech France SAS Amplitude Surgical SAS Subsidiary Company Any other transaction Outstanding Receivables - Loans 0.00 N.A. 0.00 79,382.20 79,251.40
467 Zydus Medtech France SAS Amplitude SAS [France] Subsidiary Company Interest received 0.00 N.A. 63.40 0.00 0.00
468 Zydus Medtech France SAS Amplitude SAS [France] Subsidiary Company Any other transaction Outstanding Receivables - Loans 0.00 N.A. 0.00 6,258.10 678.80
469 Amplitude SAS [France] SCI Les Tilleuls [France] Subsidiary Company Purchase of goods or services 0.00 Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. 641.70 0.00 0.00
470 Amplitude SAS [France] SCI SOFAB FALLA [France] Subsidiary Company Purchase of goods or services 0.00 Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. 317.60 0.00 0.00
471 Amplitude SAS [France] Amplitude Ile de France [France] Subsidiary Company Purchase of goods or services 0.00 Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. 1,262.70 0.00 0.00
472 Amplitude SAS [France] Duotech Amplitude SAS [France] Subsidiary Company Purchase of goods or services 0.00 Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. 778.10 0.00 0.00
473 Amplitude SAS [France] Amplitude Sud SAS [France] Subsidiary Company Purchase of goods or services 0.00 Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. 607.90 0.00 0.00
474 Amplitude SAS [France] Amplitude Nord SAS [France] Subsidiary Company Purchase of goods or services 0.00 Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. 790.90 0.00 0.00
475 Amplitude SAS [France] Ortho Santé (Amplitude Ouest) [France] Subsidiary Company Purchase of goods or services 0.00 Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. 1,019.90 0.00 0.00
476 Amplitude SAS [France] Amplitude Australia Pty Ltd [Australia] Subsidiary Company Sale of goods or services 0.00 Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. 1,270.40 0.00 0.00
477 Amplitude SAS [France] Amplitude South Africa Pty Ltd [South Africa] Subsidiary Company Sale of goods or services 0.00 Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. 331.60 0.00 0.00
478 Amplitude SAS [France] Amplitude Latin America SA [Brazil] Subsidiary Company Sale of goods or services 0.00 Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. 1,823.50 0.00 0.00
479 Amplitude SAS [France] Amplitude Benelux [Belgium] Subsidiary Company Sale of goods or services 0.00 Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. 1,171.40 0.00 0.00
480 Amplitude SAS [France] Amplitude Suisse SA [Switzerland] Subsidiary Company Sale of goods or services 0.00 Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. 128.30 0.00 0.00
481 Amplitude SAS [France] Amplitude GmbH [Germany] Subsidiary Company Sale of goods or services 0.00 Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. 103.90 0.00 0.00
482 Amplitude SAS [France] Amplitude Ile de France [France] Subsidiary Company Sale of goods or services 0.00 Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. 67.30 0.00 0.00
483 Amplitude SAS [France] Amplitude Sud SAS [France] Subsidiary Company Sale of goods or services 0.00 Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. 16.80 0.00 0.00
484 Amplitude SAS [France] Amplitude Nord SAS [France] Subsidiary Company Sale of goods or services 0.00 Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. 5.20 0.00 0.00
485 Amplitude SAS [France] Ortho Santé (Amplitude Ouest) [France] Subsidiary Company Sale of goods or services 0.00 Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. 16.80 0.00 0.00
486 Amplitude SAS [France] Amplitude Benelux [Belgium] Subsidiary Company Sale of goods or services 0.00 Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. 211.70 0.00 0.00
487 Amplitude SAS [France] Amplitude Orthopedics Corporation [USA] Subsidiary Company Interest received 0.00 N.A. 71.40 0.00 0.00
488 Amplitude SAS [France] Amplitude Australia Pty Ltd [Australia] Subsidiary Company Sale of goods or services 0.00 Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. 3.80 0.00 0.00
489 Amplitude SAS [France] Amplitude Australia Pty Ltd [Australia] Subsidiary Company Purchase of goods or services 0.00 Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. 59.80 0.00 0.00
490 Amplitude SAS [France] Amplitude Australia Pty Ltd [Australia] Subsidiary Company Interest received 0.00 N.A. 230.70 0.00 0.00
491 Amplitude SAS [France] Amplitude South Africa Pty Ltd [South Africa] Subsidiary Company Interest received 0.00 N.A. 84.30 0.00 0.00
492 Amplitude SAS [France] Amplitude Benelux [Belgium] Subsidiary Company Interest received 0.00 N.A. 36.00 0.00 0.00
493 Amplitude SAS [France] Amplitude Suisse SA [Switzerland] Subsidiary Company Sale of goods or services 0.00 Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. 2.20 0.00 0.00
494 Amplitude SAS [France] Amplitude Suisse SA [Switzerland] Subsidiary Company Interest received 0.00 N.A. 13.70 0.00 0.00
495 Amplitude SAS [France] Amplitude GmbH [Germany] Subsidiary Company Interest received 0.00 N.A. 17.00 0.00 0.00
496 Amplitude SAS [France] SCI Les Tilleuls [France] Subsidiary Company Interest paid 0.00 N.A. 57.20 0.00 0.00
497 Amplitude SAS [France] SCI SOFAB FALLA [France] Subsidiary Company Interest paid 0.00 N.A. 1.70 0.00 0.00
498 Amplitude SAS [France] Amplitude Ile de France [France] Subsidiary Company Interest paid 0.00 N.A. 3.70 0.00 0.00
499 Amplitude SAS [France] Duotech Amplitude SAS [France] Subsidiary Company Interest paid 0.00 N.A. 0.50 0.00 0.00
500 Amplitude SAS [France] Amplitude Sud SAS [France] Subsidiary Company Interest paid 0.00 N.A. 9.40 0.00 0.00
501 Amplitude SAS [France] Amplitude Nord SAS [France] Subsidiary Company Interest paid 0.00 N.A. 4.80 0.00 0.00
502 Amplitude SAS [France] Ortho Santé (Amplitude Ouest) [France] Subsidiary Company Interest paid 0.00 N.A. 4.00 0.00 0.00
503 Amplitude SAS [France] Amplitude New Zealand, New Zealand Subsidiary Company Sale of goods or services 0.00 Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. 15.20 0.00 0.00
504 Amplitude SAS [France] Amplitude New Zealand, New Zealand Subsidiary Company Interest received 0.00 N.A. 3.10 0.00 0.00
505 Amplitude SAS [France] Amplitude New Zealand, New Zealand Subsidiary Company Any other transaction Outstanding Receivables - Loans 0.00 N.A. 0.00 0.00 433.20
506 Amplitude SAS [France] Amplitude New Zealand, New Zealand Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 0.00 3.70
507 Amplitude SAS [France] Amplitude New Zealand, New Zealand Subsidiary Company Any other transaction Outstanding Payables - Loans 0.00 N.A. 0.00 108.80 0.00
508 Amplitude SAS [France] Amplitude New Zealand, New Zealand Subsidiary Company Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 311.10 0.00
509 Amplitude SAS [France] SCI Les Tilleuls [France] Subsidiary Company Any other transaction Outstanding Payables - Loans 0.00 N.A. 0.00 3,467.90 3,867.00
510 Amplitude SAS [France] SCI SOFAB FALLA [France] Subsidiary Company Any other transaction Outstanding Payables - Loans 0.00 N.A. 0.00 102.30 104.20
511 Amplitude SAS [France] Amplitude Ile de France [France] Subsidiary Company Any other transaction Outstanding Payables - Loans 0.00 N.A. 0.00 174.00 250.30
512 Amplitude SAS [France] Aptitude Orthopedie [France] Subsidiary Company Purchase of goods or services 0.00 Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. 13.20 0.00 0.00
513 Amplitude SAS [France] Aptitude Orthopedie [France] Subsidiary Company Sale of goods or services 0.00 Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. 2.20 0.00 0.00
514 Amplitude SAS [France] Aptitude Orthopedie [France] Subsidiary Company Interest paid 0.00 N.A. 0.50 0.00 0.00
515 Amplitude SAS [France] Aptitude Orthopedie [France] Subsidiary Company Any other transaction Outstanding Payables - Loans 0.00 N.A. 0.00 0.00 86.70
516 Amplitude SAS [France] Aptitude Orthopedie [France] Subsidiary Company Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 0.00 5.20
517 Amplitude SAS [France] Aptitude Orthopedie [France] Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 0.00 2.60
518 Amplitude SAS [France] FBC Medical [France] Subsidiary Company Purchase of goods or services 0.00 Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. 377.80 0.00 0.00
519 Amplitude SAS [France] FBC Medical [France] Subsidiary Company Sale of goods or services 0.00 Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. 2.30 0.00 0.00
520 Amplitude SAS [France] FBC Medical [France] Subsidiary Company Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 0.00 280.00
521 Amplitude SAS [France] FBC Medical [France] Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 0.00 2.80
522 Amplitude SAS [France] Mediconseil Subsidiary Company Purchase of goods or services 0.00 Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. 803.00 0.00 0.00
523 Amplitude SAS [France] Mediconseil Subsidiary Company Sale of goods or services 0.00 Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. 2.00 0.00 0.00
524 Amplitude SAS [France] Mediconseil Subsidiary Company Interest paid 0.00 N.A. 8.30 0.00 0.00
525 Amplitude SAS [France] Mediconseil Subsidiary Company Any other transaction Outstanding Payables - Loans 0.00 N.A. 0.00 407.90 452.50
526 Amplitude SAS [France] Mediconseil Subsidiary Company Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 380.70 480.70
527 Amplitude SAS [France] Mediconseil Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 5.40 4.70
528 Amplitude SAS [France] Duotech Amplitude SAS [France] Subsidiary Company Sale of goods or services 0.00 Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. 4.00 0.00 0.00
529 Amplitude SAS [France] Duotech Amplitude SAS [France] Subsidiary Company Any other transaction Outstanding Receivables - Loans 0.00 N.A. 0.00 12.00 0.00
530 Amplitude SAS [France] Duotech Amplitude SAS [France] Subsidiary Company Any other transaction Outstanding Payables - Loans 0.00 N.A. 0.00 0.00 277.40
531 Amplitude SAS [France] Amplitude Sud SAS [France] Subsidiary Company Any other transaction Outstanding Payables - Loans 0.00 N.A. 0.00 505.80 696.40
532 Amplitude SAS [France] Amplitude Nord SAS [France] Subsidiary Company Any other transaction Outstanding Payables - Loans 0.00 N.A. 0.00 194.70 514.20
533 Amplitude SAS [France] Ortho Santé (Amplitude Ouest) [France] Subsidiary Company Any other transaction Outstanding Payables - Loans 0.00 N.A. 0.00 249.10 253.10
534 Amplitude SAS [France] Amplitude Latin America SA [Brazil] Subsidiary Company Sale of goods or services 0.00 Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. 34.90 0.00 0.00
535 Amplitude SAS [France] SCI Les Tilleuls [France] Subsidiary Company Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 28.30 105.00
536 Amplitude SAS [France] SCI SOFAB FALLA [France] Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 0.00 134.70
537 Amplitude SAS [France] SCI SOFAB FALLA [France] Subsidiary Company Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 50.00 209.70
538 Amplitude SAS [France] Amplitude Ile de France [France] Subsidiary Company Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 738.60 466.40
539 Amplitude SAS [France] Duotech Amplitude SAS [France] Subsidiary Company Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 324.20 305.40
540 Amplitude SAS [France] Amplitude Sud SAS [France] Subsidiary Company Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 357.90 236.90
541 Amplitude SAS [France] Amplitude Nord SAS [France] Subsidiary Company Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 461.20 309.60
542 Amplitude SAS [France] Ortho Santé (Amplitude Ouest) [France] Subsidiary Company Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 517.80 473.10
543 Amplitude SAS [France] Amplitude Orthopedics Corporation [USA] Subsidiary Company Any other transaction Outstanding Receivables - Loans 0.00 N.A. 0.00 6,851.00 7,044.30
544 Amplitude SAS [France] Amplitude Australia Pty Ltd [Australia] Subsidiary Company Any other transaction Outstanding Receivables - Loans 0.00 N.A. 0.00 22,479.40 23,405.00
545 Amplitude SAS [France] Amplitude South Africa Pty Ltd [South Africa] Subsidiary Company Sale of goods or services 0.00 Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. 2.70 0.00 0.00
546 Amplitude SAS [France] Amplitude South Africa Pty Ltd [South Africa] Subsidiary Company Loan 0.00 Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. 1,539.20 0.00 0.00
547 Amplitude SAS [France] Amplitude South Africa Pty Ltd [South Africa] Subsidiary Company Any other transaction Outstanding Receivables - Loans 0.00 N.A. 0.00 5,069.10 4,099.90
548 Amplitude SAS [France] SCI Les Tilleuls [France] Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 0.00 16.10
549 Amplitude SAS [France] SCI Les Tilleuls [France] Subsidiary Company Any other transaction Outstanding Receivables - Loans 0.00 N.A. 0.00 233.90 0.00
550 Amplitude SAS [France] Amplitude Benelux [Belgium] Subsidiary Company Any other transaction Outstanding Receivables - Loans 0.00 N.A. 0.00 2,338.80 2,262.30
551 Amplitude SAS [France] Amplitude Suisse SA [Switzerland] Subsidiary Company Any other transaction Outstanding Receivables - Loans 0.00 N.A. 0.00 1,451.10 1,356.00
552 Amplitude SAS [France] Amplitude GmbH [Germany] Subsidiary Company Sale of goods or services 0.00 Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. 0.40 0.00 0.00
553 Amplitude SAS [France] Amplitude GmbH [Germany] Subsidiary Company Any other transaction Outstanding Receivables - Loans 0.00 N.A. 0.00 1,107.40 1,051.90
554 Amplitude SAS [France] Amplitude Australia Pty Ltd [Australia] Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 872.40 617.10
555 Amplitude SAS [France] Amplitude South Africa Pty Ltd [South Africa] Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 140.30 100.10
556 Amplitude SAS [France] Amplitude Latin America SA [Brazil] Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 6,013.40 0.00
557 Amplitude SAS [France] Amplitude Ile de France [France] Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 45.70 44.90
558 Amplitude SAS [France] Duotech Amplitude SAS [France] Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 4.40 3.80
559 Amplitude SAS [France] Amplitude Sud SAS [France] Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 15.30 6.20
560 Amplitude SAS [France] Amplitude Nord SAS [France] Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 15.20 3.80
561 Amplitude SAS [France] Ortho Santé (Amplitude Ouest) [France] Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 43.50 34.40
562 Amplitude SAS [France] Amplitude Benelux [Belgium] Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 644.00 655.10
563 Amplitude SAS [France] Amplitude Suisse SA [Switzerland] Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 105.50 50.60
564 Amplitude SAS [France] Amplitude GmbH [Germany] Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 95.70 24.60
565 Amplitude Surgical SAS Amplitude SAS [France] Subsidiary Company Sale of goods or services 0.00 Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. 1,327.60 0.00 0.00
566 Amplitude Surgical SAS Amplitude SAS [France] Subsidiary Company Loan 0.00 Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. 31,038.50 0.00 0.00
567 Amplitude Surgical SAS Amplitude SAS [France] Subsidiary Company Interest received 0.00 N.A. 1,345.40 0.00 0.00
568 Amplitude Surgical SAS SCI Les Tilleuls [France] Subsidiary Company Interest received 0.00 N.A. 48.40 0.00 0.00
569 Amplitude Surgical SAS Amplitude SAS [France] Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 2.40 0.00
570 Amplitude Surgical SAS Amplitude SAS [France] Subsidiary Company Any other transaction Outstanding Receivables - Loans 0.00 N.A. 0.00 38,706.10 7,408.80
571 Amplitude Surgical SAS SCI Les Tilleuls [France] Subsidiary Company Any other transaction Outstanding Receivables - Loans 0.00 N.A. 0.00 2,760.30 3,217.20
572 Amplitude Ile de France [France] Duotech Amplitude SAS [France] Subsidiary Company Sale of goods or services 0.00 Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. 4.70 0.00 0.00
573 Amplitude Ile de France [France] Amplitude Sud SAS [France] Subsidiary Company Sale of goods or services 0.00 Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. 4.90 0.00 0.00
574 Amplitude Ile de France [France] Amplitude Sud SAS [France] Subsidiary Company Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 9.20 0.00
575 Amplitude Ile de France [France] Duotech Amplitude SAS [France] Subsidiary Company Purchase of goods or services 0.00 Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. 9.60 0.00 0.00
576 Amplitude Ile de France [France] Duotech Amplitude SAS [France] Subsidiary Company Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 4.00 5.90
577 Amplitude Ile de France [France] Duotech Amplitude SAS [France] Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 2.70 2.80
578 Amplitude Ile de France [France] Amplitude Sud SAS [France] Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 2.80 2.90
579 Amplitude Ile de France [France] Amplitude Nord SAS [France] Subsidiary Company Purchase of goods or services 0.00 Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. 20.40 0.00 0.00
580 Amplitude Ile de France [France] Amplitude Nord SAS [France] Subsidiary Company Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 4.90 8.80
581 Amplitude Ile de France [France] Amplitude Nord SAS [France] Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 2.00 0.00
582 Comfort Click Limited (Ireland) Comfort Click Limited (UK) Subsidiary Company Any other transaction Reimbursement of Expenses Recovered 0.00 N.A. 17,216.00 0.00 0.00
583 Comfort Click Softech Pvt. Ltd. Comfort Click Limited (UK) Subsidiary Company Sale of goods or services 0.00 Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. 1,846.60 0.00 0.00
584 Comfort Click Limited (UK) Comfort Click Limited (Ireland) Subsidiary Company Sale of goods or services 0.00 Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. 119.40 0.00 0.00
585 Comfort Click Limited (UK) Comfort Click Limited (Ireland) Subsidiary Company Any other transaction Reimbursement of Expenses paid 0.00 N.A. 126.60 0.00 0.00
586 Comfort Click Limited (UK) Comfort Click Limited (Ireland) Subsidiary Company Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 1,373.40 1,379.50
587 Alidac UK Limited Comfort Click Limited (UK) Subsidiary Company Any other transaction Reimbursement of Expenses Recovered 0.00 N.A. 1.00 0.00 0.00
588 Comfort Click Limited (UK) Comfort Click LLC (USA) Subsidiary Company Any other transaction Reimbursement of Expenses Recovered 0.00 N.A. 2.20 0.00 0.00
589 Comfort Click Limited (UK) Comfort Click LLC (USA) Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 0.00 41.00
590 Comfort Click Limited (UK) Zydus Wellness (EU) Limited [Ireland] Subsidiary Company Any other transaction Reimbursement of Expenses Recovered 0.00 N.A. 6.50 0.00 0.00
591 Comfort Click Limited (UK) Zydus Wellness (EU) Limited [Ireland] Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 0.00 6.50
592 Comfort Click Limited (UK) Comfort Click Softech Pvt. Ltd. Subsidiary Company Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 303.30 0.00
593 Assertio Management LLC [USA] Assertio Holdings Inc. [USA] Subsidiary Company Any other transaction Reimbursement of Expenses Recovered 0.00 N.A. 4,155.60 0.00 0.00
594 Zyla Life Sciences US LLC [USA] Assertio Holdings Inc. [USA] Subsidiary Company Any other transaction Reimbursement of Expenses Recovered 0.00 N.A. 21,688.90 0.00 0.00
595 Zyla Life Sciences US LLC [USA] Zyla Life Sciences Limited [USA] Subsidiary Company Any other transaction Reimbursement of Expenses Recovered 0.00 N.A. 4,899.80 0.00 0.00
596 Zyla Life Sciences US LLC [USA] Assertio Holdings Inc. [USA] Subsidiary Company Any other transaction Reimbursement of Expenses Recovered 0.00 N.A. 21,689.80 0.00 0.00
597 Assertio Distribution LLC [USA] Zyla Life Sciences US LLC [USA] Subsidiary Company Any other transaction Reimbursement of Expenses Recovered 0.00 N.A. 14,274.00 0.00 0.00
598 Assertio Management LLC [USA] Zyla Life Sciences US LLC [USA] Subsidiary Company Any other transaction Reimbursement of Expenses Recovered 0.00 N.A. 14.30 0.00 0.00
599 Assertio Specialty Pharmaceuticals LLC [USA] Assertio Management LLC [USA] Subsidiary Company Any other transaction Reimbursement of Expenses Recovered 0.00 N.A. 7,666.10 0.00 0.00
600 Assertio Specialty Pharmaceuticals LLC [USA] Assertio Management LLC [USA] Subsidiary Company Any other transaction Reimbursement of Expenses Recovered 0.00 N.A. 2,750.10 0.00 0.00
601 Assertio Distribution LLC [USA] Assertio Specialty Pharmaceuticals LLC [USA] Subsidiary Company Any other transaction Reimbursement of Expenses Recovered 0.00 N.A. 10,106.90 0.00 0.00
602 Asio Holdings LLC [USA] Assertio Specialty Pharmaceuticals LLC [USA] Subsidiary Company Any other transaction Reimbursement of Expenses Recovered 0.00 N.A. 471.00 0.00 0.00
603 Assertio Distribution LLC [USA] Assertio Specialty Pharmaceuticals LLC [USA] Subsidiary Company Any other transaction Reimbursement of Expenses Recovered 0.00 N.A. 2,279.10 0.00 0.00
604 Spectrum Pharmaceuticals Inc. [USA] Assertio Management LLC [USA] Subsidiary Company Any other transaction Reimbursement of Expenses Recovered 0.00 N.A. 1,051.50 0.00 0.00
605 Assertio Distribution LLC [USA] Spectrum Pharmaceuticals Inc. [USA] Subsidiary Company Any other transaction Reimbursement of Expenses Recovered 0.00 N.A. 578.60 0.00 0.00
606 Assertio Distribution LLC [USA] Spectrum Pharmaceuticals Inc. [USA] Subsidiary Company Any other transaction Reimbursement of Expenses Recovered 0.00 N.A. 579.50 0.00 0.00
607 Assertio Distribution LLC [USA] Assertio Management LLC [USA] Subsidiary Company Any other transaction Reimbursement of Expenses Recovered 0.00 N.A. 6,918.10 0.00 0.00
608 Assertio Distribution LLC [USA] Zyla Life Sciences US LLC [USA] Subsidiary Company Any other transaction Reimbursement of Expenses Recovered 0.00 N.A. 14,274.00 0.00 0.00
609 Assertio Distribution LLC [USA] Assertio Specialty Pharmaceuticals LLC [USA] Subsidiary Company Any other transaction Reimbursement of Expenses Recovered 0.00 N.A. 10,106.90 0.00 0.00
610 Assertio Distribution LLC [USA] Asio Holdings LLC [USA] Subsidiary Company Any other transaction Reimbursement of Expenses Recovered 0.00 N.A. 2,279.10 0.00 0.00
611 Assertio Management LLC [USA] Assertio Holdings Inc. [USA] Subsidiary Company Any other transaction Reimbursement of Expenses Recovered 0.00 N.A. 101.80 0.00 0.00
612 Assertio Management LLC [USA] Zyla Life Sciences US LLC [USA] Subsidiary Company Any other transaction Reimbursement of Expenses Recovered 0.00 N.A. 14.30 0.00 0.00
613 Assertio Management LLC [USA] Assertio Holdings Inc. [USA] Subsidiary Company Any other transaction Reimbursement of Expenses Recovered 0.00 N.A. 4,051.90 0.00 0.00
614 Assertio Distribution LLC [USA] Assertio Management LLC [USA] Subsidiary Company Any other transaction Reimbursement of Expenses Recovered 0.00 N.A. 6,917.20 0.00 0.00
615 Assertio Specialty Pharmaceuticals LLC [USA] Assertio Management LLC [USA] Subsidiary Company Any other transaction Reimbursement of Expenses Recovered 0.00 N.A. 7,666.10 0.00 0.00
616 Spectrum Pharmaceuticals Inc. [USA] Assertio Management LLC [USA] Subsidiary Company Any other transaction Reimbursement of Expenses Recovered 0.00 N.A. 1,051.50 0.00 0.00
617 Asio Holdings LLC [USA] Assertio Management LLC [USA] Subsidiary Company Any other transaction Reimbursement of Expenses Recovered 0.00 N.A. 2,750.10 0.00 0.00
618 Zyla Life Sciences Limited [USA] Assertio Holdings Inc. [USA] Subsidiary Company Interest received 0.00 N.A. 2,472.30 0.00 0.00
619 Assertio Specialty Pharmaceuticals LLC [USA] Assertio Holdings Inc. [USA] Subsidiary Company Interest received 0.00 N.A. 1,875.60 0.00 0.00
620 Assertio Holdings Inc. [USA] Assertio Management LLC [USA] Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 0.00 49,328.30
621 Assertio Management LLC [USA] Assertio Holdings Inc. [USA] Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 0.00 102.20
622 Zyla Life Sciences US LLC [USA] Assertio Holdings Inc. [USA] Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 0.00 61,579.40
623 Assertio Specialty Pharmaceuticals LLC [USA] Assertio Distribution LLC [USA] Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 0.00 10,291.00
624 Zyla Life Sciences US LLC [USA] Zyla Life Sciences Limited [USA] Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 0.00 1,29,335.70
625 Zyla Life Sciences Limited [USA] Zyla Life Sciences US LLC [USA] Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 0.00 2,27,177.10
626 Assertio Management LLC [USA] Assertio Specialty Pharmaceuticals LLC [USA] Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 0.00 56,184.90
627 Assertio Management LLC [USA] Spectrum Pharmaceuticals Inc. [USA] Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 0.00 28,795.30
628 Assertio Distribution LLC [USA] Spectrum Pharmaceuticals Inc. [USA] Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 0.00 583.40
629 Spectrum Pharmaceuticals Inc. [USA] Spectrum Oncology Private Limited Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 0.00 121.10
630 Assertio Management LLC [USA] Asio Holdings LLC [USA] Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 0.00 4,794.90
631 Assertio Distribution LLC [USA] Asio Holdings LLC [USA] Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 0.00 1,148.00
632 Assertio Distribution LLC [USA] Assertio Management LLC [USA] Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 0.00 468.40
633 Assertio Distribution LLC [USA] Zyla Life Sciences US LLC [USA] Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 0.00 744.20
634 Zyla Life Sciences US LLC [USA] Assertio Management LLC [USA] Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 0.00 22,164.60
635 Assertio Holdings Inc. [USA] Zyla Life Sciences Limited [USA] Subsidiary Company Any other transaction Outstanding Receivables - Loans 0.00 N.A. 0.00 0.00 74,565.40
636 Assertio Holdings Inc. [USA] Assertio Specialty Pharmaceuticals LLC [USA] Subsidiary Company Any other transaction Outstanding Receivables - Loans 0.00 N.A. 0.00 0.00 56,571.90
Total value of transaction during the reporting period 11,88,028.40



Text Block

Textual Information(1) Purchase / Subscription of Investments. Opening and closing balance are not given where there was no transaction of Investment during the half year ended September 30, 2026.
Textual Information(2) Loan Given 6 Month T Bill + 80 BPS
Textual Information(3) Purchase / Subscription of Investments.
Textual Information(4) Purchase / Subscription of Investments.
Textual Information(5) Loan Given 1 Month T Bill + 95 BPS
Textual Information(6) Loan Given
Textual Information(7) Loan Given 3 Month SOFR + 50 BPS
Textual Information(8) Loan Given 3 Month SOFR + 50 BPS
Textual Information(9) Loan Given 3 Month SOFR + 50 BPS
Textual Information(10) Loan Given 3 Month SOFR + 50 BPS
Textual Information(11) Loan Given 3 Month SOFR + 50 BPS
Textual Information(12) Loan given 6 Month SOFR + 85 BPS
Textual Information(13) Purchase / Subscription of Investments.